5/23/2024 | SP | New Issue: Citigroup prices $20 million 14.4% contingent income autocalls on Bristol-Myers Squibb
|
5/12/2024 | SP | New Issue: Citigroup prices $10 million 15% autocallable phoenix securities linked to BMS
|
5/7/2024 | SP | New Issue: Citigroup prices $10 million 12.2% autocallable phoenix securities linked to BMS
|
5/3/2024 | SP | New Issue: BofA sells $3.3 million market-linked autocalls with buffered downside on stocks
|
4/21/2024 | SP | New Issue: Barclays sells $540,000 autocallable contingent coupon notes on two stocks
|
4/11/2024 | SP | New Issue: JPMorgan sells $2.4 million trigger autocallable contingent yield notes on stock
|
4/2/2024 | SP | New Issue: Barclays prices $1.66 million contingent coupon autocalls on Bristol-Myers Squibb
|
3/25/2024 | SP | New Issue: HSBC prices $5.33 million contingent income barrier autocallables with memory on stock
|
3/8/2024 | SP | New Issue: JPMorgan sells $4.18 million trigger autocallable contingent yield notes on BMS
|
2/16/2024 | IG | Market Commentary: Heavy high-grade bond supply eyed in short holiday week; energy space strong
|
2/15/2024 | SP | New Issue: Barclays prices $745,000 phoenix autocallable notes tied to three stocks
|
2/15/2024 | IG | New Issue: Bristol-Myers Squibb details $13 billion of notes in nine-part offer
|
2/14/2024 | IG | Bristol-Myers Squibb prices $13 billion of notes in nine-part offer
|
2/14/2024 | BKIG | Moody’s gives Bristol-Myers notes A2
|
2/14/2024 | BKIG | S&P assigns A to Bristol-Myers notes
|
2/13/2024 | IG | Bristol-Myers Squibb to price notes offering in eight tranches
|
2/12/2024 | SP | New Issue: UBS prices $3.4 million 8.6% trigger callable yield notes on two stocks
|
2/12/2024 | BKIG | Moody’s views Bristol-Myers negatively
|
2/9/2024 | IG | Market Commentary: Busy high-grade corporate deal pace continues; M&A-related supply increases; flows up
|
2/8/2024 | SP | New Issue: GS Finance sells $2.55 million leveraged market-linked buffered autocalls on stocks
|
2/2/2024 | SP | New Issue: GS Finance sells $4.9 million autocallable contingent coupon equity notes on BMS
|
2/1/2024 | SP | New Issue: Barclays prices $375,000 autocallable contingent coupon notes on three stocks
|
2/1/2024 | SP | New Issue: BMO prices $2.22 million autocallable barrier notes with contingent coupons on Bristol-Myers Squibb
|
1/29/2024 | SP | New Issue: BofA prices $1.76 million contingent income autocallables tied to Bristol-Myers Squibb
|
1/16/2024 | SP | New Issue: Barclays prices $5.61 million phoenix autocallable notes on Bristol-Myers Squibb
|
1/15/2024 | SP | New Issue: Barclays prices $2 million phoenix autocallable notes tied to three stocks
|
12/22/2023 | BKIG | Moody’s reviews Bristol-Myers for trim
|
12/22/2023 | BKIG | Bristol-Myers Squibb to take on new debt for $14 billion Karuna buy
|
12/22/2023 | SP | New Issue: HSBC prices $4.97 million 10.33% contingent income barrier autocalls with memory on Bristol Myers
|
12/13/2023 | SP | New Issue: BMO sells $4.36 million autocallable barrier notes with contingent coupon on stock
|
12/5/2023 | SP | New Issue: BMO sells $1.3 million enhanced return notes on Bristol-Myers Squibb
|
10/30/2023 | IG | New Issue: Bristol-Myers Squibb sells $4.5 billion of senior notes in four parts
|
10/30/2023 | BKIG | S&P assigns A+ to Bristol-Myers notes
|
10/30/2023 | BKIG | Moody’s gives Bristol-Myers notes A2
|
10/30/2023 | IG | Bristol-Myers Squibb to price notes offering in four tranches
|
8/31/2023 | SP | New Issue: UBS sells $2.33 million capped trigger gears on basket of 40 stocks
|
6/22/2023 | SP | New Issue: JPMorgan prices $500,000 buffered digital notes linked to Bristol-Myers, Goldman
|
5/26/2023 | SP | New Issue: BMO sells $808,000 autocallable barrier notes with contingent coupon on Bristol-Myers
|
1/24/2023 | SP | New Issue: CIBC prices $1.05 million Accelerated Return Notes on basket of healthcare stocks
|
12/30/2022 | LM | Outlook 2023: Ukraine debt deferral leads overall smaller year in LM exercises
|
11/13/2022 | SP | New Issue: UBS prices $1.12 million contingent income autocalls on Bristol-Myers
|
8/18/2022 | SP | New Issue: UBS sells $1.03 million trigger autocallable contingent yield notes on Bristol-Myers
|
6/8/2022 | SP | New Issue: JPMorgan prices $750,000 autocallable contingent interest notes on pharma stocks
|
5/16/2022 | SP | New Issue: JPMorgan prices $585,000 autocallable contingent interest notes linked to BMS
|
5/3/2022 | SP | New Issue: JPMorgan sells $550,000 autocallable yield notes on three stocks
|
4/22/2022 | SP | New Issue: RBC sells $301,000 notes on basket of 40 Raymond James stock picks
|
4/22/2022 | SP | New Issue: RBC sells $2.86 million notes on basket of 40 Raymond James stock picks
|
3/31/2022 | SP | New Issue: GS Finance sells $3.82 million contingent income autocalls on Bristol-Myers Squibb
|
3/2/2022 | IGLM | Bristol-Myers details early tender amounts and pricing, tweaks offer
|
3/2/2022 | IGLM | Bristol-Myers Squibb details early tender amounts, tweaks offer
|
2/22/2022 | BKIG | S&P turns Bristol-Myers view to stable
|
2/15/2022 | IG | New Issue: Bristol-Myers Squibb sells $6 billion of senior notes in four parts
|
2/15/2022 | BKIG | S&P rates Bristol-Myers Squibb notes A+
|
2/15/2022 | BKIG | Moody's gives A2 to Bristol-Myers notes
|
2/15/2022 | IGLM | Bristol-Myers Squibb to buy notes from 22 series for up to $4 billion
|
2/15/2022 | IG | Bristol-Myers Squibb to price notes offering in four tranches
|
12/17/2021 | SP | New Issue: Credit Suisse sells $3.83 million contingent coupon autocallable yield notes on stocks
|
11/24/2021 | SP | New Issue: UBS prices $280,000 trigger phoenix autocallables linked to Bristol-Myers
|
11/24/2021 | SP | New Issue: UBS prices $482,000 trigger phoenix autocallables linked to Bristol-Myers
|
11/24/2021 | SP | New Issue: UBS prices $1.15 million trigger phoenix autocallables linked to Bristol-Myers
|
11/12/2021 | SP | New Issue: UBS prices $399,979 5.37% trigger yield optimization notes linked to Bristol-Myers
|
10/18/2021 | SP | New Issue: JPMorgan sells $6.11 million review notes tied to three stocks
|
10/15/2021 | SP | New Issue: UBS prices $720,000 trigger phoenix autocallables linked to Bristol-Myers
|
10/15/2021 | SP | New Issue: UBS prices $366,000 trigger phoenix autocallables linked to Bristol-Myers
|
10/15/2021 | SP | New Issue: UBS prices $135,000 trigger phoenix autocallables linked to Bristol-Myers
|
10/15/2021 | SP | New Issue: UBS prices $257,000 trigger phoenix autocallables linked to Bristol-Myers
|
10/13/2021 | SP | New Issue: UBS prices $5.36 million phoenix autocallable notes on Apple, Bristol-Myers Squibb
|
10/1/2021 | SP | New Issue: UBS prices $17.17 million trigger autocallable contingent yield notes on Bristol-Myers Squibb
|
9/16/2021 | SP | New Issue: Citi sells $5.21 million callable contingent coupon equity notes on three stocks
|
9/1/2021 | SP | New Issue: GS Finance prices $10.08 million contingent income autocalls on Bristol-Myers
|
8/6/2021 | SP | New Issue: GS Finance sells $535,000 contingent income autocallables on Bristol-Myers Squibb
|
7/24/2021 | SP | New Issue: UBS prices $2.35 million contingent income autocalls on Bristol-Myers
|
6/29/2021 | SP | New Issue: Citigroup prices $3.6 million contingent income autocalls on Bristol-Myers Squibb
|
6/22/2021 | SP | New Issue: UBS prices $5.07 million contingent income autocalls on pharma stocks
|
5/19/2021 | SP | New Issue: Morgan Stanley sells $1.12 million contingent income autocalls on Bristol-Myers Squibb
|
4/8/2021 | SP | New Issue: JPMorgan sells $550,000 autocallable yield notes on three stocks
|
4/1/2021 | SP | New Issue: UBS sells $1.89 million trigger autocallable contingent yield notes on pharma stocks
|
3/18/2021 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/10/2021 | SP | New Issue: GS Finance prices $12.36 million contingent income autocallables on Bristol-Myers
|
2/22/2021 | IGLM | Bristol-Myers, Celgene to redeem 4% notes, 3.25% notes due 2023
|
2/22/2021 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/21/2021 | SP | New Issue: Citi sells $4.16 million autocallable contingent coupon equity notes on two stocks
|
2/19/2021 | IGLM | Bristol-Myers Squibb announces pricing on tender offers for 20 series
|
2/19/2021 | IGLM | Bristol-Myers Squibb gives early results of tender offers for 20 series
|
2/9/2021 | SP | New Issue: UBS sells $3.39 million trigger autocallable contingent yield notes on Bristol-Myers Squibb
|
2/4/2021 | BKIG | Moody’s shifts Bristol-Myers view to stable
|
2/4/2021 | BWIGLM | Bristol-Myers starts leverage reduction goal with $4 billion tender
|
2/4/2021 | IGLM | Bristol-Myers Squibb kicks off $4 billion tender offers for 20 series
|
2/2/2021 | BK | Bristol-Myers Squibb terminates $4 billion term loan agreement
|
12/29/2020 | SP | New Issue: GS Finance sells $1.71 million leveraged basket-linked notes on 23 stocks
|
12/16/2020 | SP | Market Commentary: Credit Suisse’s $3 million autocalls show fixed rate but dispersion risk with four stocks
|
12/16/2020 | SP | New Issue: Credit Suisse sells $3 million autocallable reverse convertibles on stocks
|
12/5/2020 | SP | New Issue: JPMorgan sells $1.09 million autocallable yield notes on Bristol-Myers
|
11/19/2020 | SP | New Issue: Credit Suisse sells $2.85 million contingent coupon autocallables on stocks
|
11/12/2020 | BKIG | Fitch rates Bristol-Myers notes
|
11/10/2020 | IG | Market Commentary: L3Harris, Rexford, Verizon, Standard Chartered, Allianz in primary; credit spreads ease
|
11/10/2020 | IG | New Issue: Bristol-Myers Squibb details $7 billion of fixed-rate senior notes in six tranches
|
11/10/2020 | IG | Market Commentary: Morning Commentary: Verizon to sell five tranches; Standard Chartered, others on deck
|
11/9/2020 | EMHYPFPV | Market Commentary: Bristol-Myers, Republic Services, Vereit, ConEd, Entergy, Ameren price
|
11/9/2020 | IG | Market Commentary: Bristol-Myers, Republic Services, Vereit, ConEd, Entergy, Ameren price; credit spreads firm
|
11/9/2020 | IG | New Issue: Bristol-Myers Squibb sells $7 billion of fixed-rate senior notes in six tranches
|
11/9/2020 | BKIG | S&P gives Bristol-Myers notes A+
|
11/9/2020 | BKIG | Moody’s assigns Bristol-Myers notes A2
|
11/9/2020 | IG | Market Commentary: Morning Commentary: High-grade supply resumes; Bristol-Myers, Vereit, Entergy on tap
|
11/9/2020 | IG | Bristol-Myers Squibb offers floaters, six series of fixed-rate notes
|
11/6/2020 | BK | Bristol-Myers Squibb enters $4 billion delayed-draw term loans
|
11/4/2020 | SP | New Issue: Citigroup prices $1.05 million contingent coupon autocallables on two stocks
|
10/22/2020 | SP | New Issue: UBS prices $3.12 million trigger autocallable contingent yield notes on Bristol-Myers
|
10/6/2020 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Bristol-Myers
|
10/5/2020 | IG | Market Commentary: Berkshire Hathaway, PepsiCo, Everest Reinsurance, Leidos, WEC Energy, Swedish Export price
|
10/5/2020 | BKBWIG | Bristol-Myers Squibb plans debt for $13.1 billion MyoKardia purchase
|
10/5/2020 | BKCVIG | S&P shifts Bristol-Myers view to negative
|
9/18/2020 | SP | New Issue: Citi sells $1 million callable contingent coupon notes on three stocks
|
9/18/2020 | SP | New Issue: Citi sells $1.7 million callable contingent coupon notes on three stocks
|
9/4/2020 | SP | New Issue: GS Finance sells $830,000 leveraged basket-linked notes on 103 stocks
|
8/27/2020 | SP | New Issue: UBS prices $1 million trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
8/20/2020 | SP | New Issue: Credit Suisse sells $4.38 million contingent income autocalls on three stocks
|
8/19/2020 | SP | New Issue: JPMorgan sells $1.25 million contingent interest autocallables on Bristol-Myers
|
8/17/2020 | SP | New Issue: Citigroup prices $1.01 million contingent coupon autocallables on three stocks
|
8/13/2020 | SP | Credit Suisse plans contingent income autocalls on three stocks
|
7/31/2020 | SP | New Issue: UBS prices $525,000 trigger phoenix autocallables linked to Bristol-Myers
|
7/31/2020 | SP | New Issue: UBS prices $625,000 trigger phoenix autocallables linked to Bristol-Myers
|
7/29/2020 | SP | New Issue: UBS prices $575,000 trigger phoenix autocallables linked to Bristol-Myers
|
7/22/2020 | SP | New Issue: UBS prices $584,000 trigger autocallable contingent yield notes on stocks
|
7/16/2020 | SP | UBS plans trigger autocallable contingent yield notes on three stocks
|
6/26/2020 | SP | New Issue: UBS prices $1.3 million contingent absolute return autocallables linked to Bristol-Myers
|
6/22/2020 | SP | New Issue: UBS prices $175,000 trigger phoenix autocallables linked to Bristol-Myers
|
6/1/2020 | SP | New Issue: Morgan Stanley sells $3.12 million contingent income autocallables on Bristol-Myers
|
5/28/2020 | SP | New Issue: UBS prices $291,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
5/26/2020 | SP | New Issue: Goldman prices $2.12 million leveraged buffered basket-linked notes on 26 stocks
|
5/15/2020 | SP | New Issue: UBS prices $125,000 trigger phoenix autocallables linked to Bristol-Myers
|
5/8/2020 | SP | New Issue: GS Finance prices $4.05 million capped trigger securities on basket of 20 stocks
|
5/7/2020 | BKBWIG | Bristol-Myers Squibb now on track for 1.5x leverage by year-end 2023
|
5/5/2020 | SP | New Issue: UBS prices $1 million of trigger autocallable contingent yield notes on two stocks
|
4/28/2020 | SP | New Issue: Goldman prices $910,000 leveraged basket-linked notes on 26 stocks
|
4/23/2020 | SP | New Issue: Goldman prices $9.16 million leveraged basket-linked notes on 26 stocks
|
4/21/2020 | SP | New Issue: BMO sells $667,000 contingent coupon autocallable reverse convertibles on Bristol-Myers
|
3/19/2020 | SP | New Issue: Credit Suisse sells $2 million 8% autocallable reverse convertibles on pharma stocks
|
2/25/2020 | SP | New Issue: HSBC sells $12.53 million contingent income autocallables on Bristol-Myers Squibb
|
2/21/2020 | SP | New Issue: Morgan Stanley sells $3.3 million contingent income autocalls on three stocks
|
2/20/2020 | SP | New Issue: Morgan Stanley sells $800,000 contingent income autocalls on four stocks
|
2/14/2020 | SP | New Issue: JPMorgan sells $548,000 contingent interest autocalls on Bristol-Myers
|
2/12/2020 | SP | New Issue: UBS prices $257,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
2/11/2020 | SP | Morgan Stanley plans contingent income autocallables on three stocks
|
2/4/2020 | SP | New Issue: BofA prices $500,000 contingent income autocallable yield notes on three stocks
|
2/3/2020 | SP | New Issue: Credit Suisse sells $1.21 million contingent coupon autocallable reverse convertibles on three stocks
|
1/30/2020 | SP | New Issue: HSBC prices $1.8 million contingent income barrier autocallables tied to three stocks
|
1/27/2020 | SP | New Issue: JPMorgan prices $860,000 contingent interest autocalls on Bristol-Myers Squibb
|
1/22/2020 | SP | New Issue: Credit Suisse $4.68 million contingent coupon autocallable yield notes on pharma stocks
|
1/16/2020 | SP | New Issue: Scotia sells $6.05 million capped enhanced participation notes on basket of 49 stocks
|
1/9/2020 | BKBWIG | Bristol-Myers Squibb expects to get leverage to 1.5x by year-end 2022
|
1/8/2020 | SP | New Issue: Barclays amends $1.68 million phoenix autocallables linked to three stocks
|
1/3/2020 | SP | New Issue: UBS prices $3.21 million contingent income autocalls on Bristol-Myers
|
12/31/2019 | IG | Outlook 2020: High-grade bond spreads mostly expected to improve; bank paper to grind tighter
|
12/30/2019 | SP | New Issue: Credit Suisse $2.77 million contingent coupon autocallable yield notes on three stocks
|
12/30/2019 | SP | New Issue: Credit Suisse $2.25 million contingent coupon autocallable yield notes on three stocks
|
12/30/2019 | SP | New Issue: Barclays prices $1.68 million phoenix autocallables linked to three stocks
|
12/24/2019 | IG | Market Commentary: High-grade primary market shuts down ahead of holidays; Charter tightens; AbbVie steady
|
12/18/2019 | EMHYPFPV | Market Commentary: High-grade corporate bond supply winds down for year; FHLBank on tap; AbbVie firms
|
12/18/2019 | IG | Market Commentary: High-grade corporate bond supply winds down for year; FHLBank on tap; AbbVie firms
|
12/16/2019 | SP | Credit Suisse plans contingent coupon autocallable yield notes on stocks
|
12/16/2019 | SP | UBS plans contingent income autocallables linked to Bristol-Myers
|
12/11/2019 | IG | Market Commentary: Sterling Bancorp offers fixed/floaters; Steel Dynamics firms; AbbVie, Bristol-Myers tight
|
12/11/2019 | SP | New Issue: UBS prices $2.44 million trigger autocallable contingent yield notes on Bristol-Myers
|
11/25/2019 | SP | UBS to price trigger autocallables linked to Bristol-Myers Squibb
|
11/25/2019 | BKIG | Fitch shifts Bristol-Myers view to negative
|
11/21/2019 | BKIG | S&P boosts Celgene, off watch
|
11/21/2019 | IGLM | Bristol-Myers announces results of exchange offers for Celgene notes
|
11/15/2019 | SP | New Issue: Barclays prices $9.66 million contingent income autocallables linked to Bristol-Myers
|
11/15/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
11/15/2019 | SP | New Issue: Wells Fargo sells $6.78 million more equity-linked notes on Bristol-Myers
|
11/15/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
11/12/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
11/8/2019 | SP | New Issue: UBS prices $504,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
11/7/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
11/6/2019 | SPSW | Structured notes post strong week with $749 million issued amid stock market rally
|
11/5/2019 | IGLM | Bristol-Myers Squibb again extends exchange offers for Celgene notes
|
11/4/2019 | SP | Barclays plans contingent income notes linked to Bristol-Myers Squibb
|
11/4/2019 | SP | New Issue: Wells Fargo sells $72.75 million equity-linked notes on Bristol-Myers
|
11/1/2019 | IGLM | Bristol-Myers Squibb again extends exchange offers for Celgene notes
|
10/30/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
10/21/2019 | SP | New Issue: UBS prices $528,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
10/21/2019 | SP | New Issue: UBS prices $795,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
10/18/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
10/15/2019 | SP | New Issue: UBS prices $200,000 contingent absolute return autocallable optimization securities linked to Bristol-Myers
|
10/8/2019 | IGLM | Bristol-Myers Squibb extends exchange offers for Celgene notes
|
10/2/2019 | SP | New Issue: Barclays sells $3.19 million phoenix autocallable notes on Bristol-Myers
|
9/24/2019 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
9/23/2019 | IGLM | Bristol-Myers Squibb again extends exchange offers for Celgene notes
|
8/26/2019 | IGLM | Bristol-Myers Squibb to pay down debt with divestiture proceeds
|
8/26/2019 | BK | Bristol-Myers Squibb to pay down debt with divestiture proceeds
|
8/19/2019 | SP | New Issue: Credit Suisse sells $1.95 million autocallable yield notes on three stocks
|
8/19/2019 | SP | New Issue: Credit Suisse sells $1.8 million contingent coupon autocallable yield notes on Bristol-Myers
|
8/7/2019 | SP | New Issue: JPMorgan prices $1.8 million contingent interest autocalls linked to pharma stocks
|
8/2/2019 | SP | New Issue: Barclays prices $16 million contingent income autocallables linked to Bristol-Myers Squibb
|
7/30/2019 | SP | New Issue: JPMorgan prices $1.84 million contingent interest autocallables linked to pharma stocks
|
7/23/2019 | SP | New Issue: UBS prices $1.34 million trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
7/15/2019 | SP | JPMorgan to price contingent interest autocallables on three stocks
|
7/5/2019 | SP | New Issue: RBC sells $1.4 million contingent coupon barrier autocalls on three stocks
|
6/28/2019 | IGLM | Bristol-Myers extends exchange offers for Celgene notes
|
6/20/2019 | SP | New Issue: UBS prices $855,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
6/6/2019 | IG | Market Commentary: Supply slows; Camden, TTX, Apollo, Inter-American Development Bank, FHLB price; inflows return
|
6/3/2019 | IG | Market Commentary: Home Depot, Public Service, Dayton Power, Wintrust price; CDP, Parker-Hannifin eye new issues
|
5/29/2019 | IG | Market Commentary: High-grade supply quiet; Dollar Tree eases, Dollar General flat ahead of earnings reports
|
5/28/2019 | IG | Market Commentary: MasterCard, San Diego Gas, Southwest Gas among issuers; Unibail-Rodamco-Westfield eyes deal
|
5/28/2019 | IG | Market Commentary: Morning Commentary: MasterCard, San Diego Gas, Southwest Gas on tap; light supply eyed
|
5/24/2019 | IGLM | Bristol-Myers extends exchange offers for Celgene notes
|
5/17/2019 | IG | Market Commentary: High-grade action quiet; steady volume on tap ahead of holiday; inflows dip; Fidelity firms
|
5/13/2019 | EMHYPFPV | Market Commentary: Nordic Investment Bank offers $1 billion; Nstar, Fidelity, Avangrid eyed
|
5/13/2019 | IG | Market Commentary: Nordic Investment Bank offers $1 billion; Nstar, Fidelity, Avangrid eyed; credit spreads ease
|
5/13/2019 | IG | Market Commentary: Morning Commentary: Nstar Electric plans green bonds; Fidelity, Avangrid deals eyed
|
5/10/2019 | EMHYPFPV | Market Commentary: High-grade supply quiet; Fidelity, Avangrid, Nstar deals eyed; IBM eases; Bristol-Myers firms
|
5/10/2019 | IG | Market Commentary: High-grade supply quiet; Fidelity, Avangrid, Nstar deals eyed; IBM eases; Bristol-Myers firms
|
5/9/2019 | EMHYPFPV | Market Commentary: Motorola, O’Reilly tap primary market; high-grade inflows rise; week’s deal volume strong
|
5/9/2019 | IG | Market Commentary: Motorola, O’Reilly tap primary market; high-grade inflows rise; week’s deal volume strong
|
5/9/2019 | IG | Market Commentary: Morning Commentary: High-grade supply robust; O’Reilly Automotive, Motorola offer notes
|
5/8/2019 | EMHYPFPV | Market Commentary: IBM prices $20 billion; Bell Canada, Reinsurance, AvalonBay, Honda, EIB among issuers
|
5/8/2019 | IG | Market Commentary: IBM prices $20 billion; Bell Canada, Reinsurance, AvalonBay, Honda, EIB among issuers
|
5/8/2019 | SP | Citi plans autocallable contingent coupon notes tied to two stocks
|
5/8/2019 | IG | Market Commentary: Morning Commentary: IBM, AvalonBay, Reinsurance Group, Bell Canada, EIB offer notes
|
5/8/2019 | IG | New Issue: Bristol-Myers prices $19 billion of senior notes in nine tranches
|
5/7/2019 | EMHYPFPV | Market Commentary: Principal Financial, Brixmor tap primary market; Bristol-Myers, Fidelity, T-Mobile eyed
|
5/7/2019 | IG | Market Commentary: Principal Financial, Brixmor tap primary market; Bristol-Myers, Fidelity, T-Mobile deals eyed
|
5/7/2019 | SP | New Issue: JPMorgan prices $4.75 million 6.05% autocallable yield notes on three stocks
|
5/7/2019 | IG | Market Commentary: Morning Commentary: Principal Financial, Brixmor on deck; heavy bond deal pipeline eyed
|
5/6/2019 | EMHYPFPV | Market Commentary: Utilities American Water, Public Service, ConEd tap primary market; M&A funding deals eyed
|
5/6/2019 | IG | Market Commentary: Utilities American Water, Public Service, ConEd tap primary market; M&A funding deals eyed
|
5/6/2019 | IG | Market Commentary: Morning Commentary: American Water, PSE&G, ConEd offer bonds; M&A funding deals eyed
|
5/3/2019 | EMHYPFPV | Market Commentary: Paccar Financial, Pacific Premier Bancorp price; heavy volume eyed; Starbucks softens
|
5/3/2019 | IG | Market Commentary: Paccar Financial, Pacific Premier Bancorp price; heavy volume eyed; Starbucks softens
|
5/3/2019 | BKIG | Fitch rates Bristol-Myers notes A-
|
5/3/2019 | IG | Market Commentary: Morning Commentary: Pacific Premier Bancorp on tap; inflows down; Starbucks softens
|
5/2/2019 | EMHYPFPV | Market Commentary: Starbucks, RBS, Eni, Florida Light in primary market; inflows decline; Bristol-Myers eyed
|
5/2/2019 | IG | Market Commentary: Starbucks, RBS, Eni, Florida Light in primary market; inflows decline; Bristol-Myers eyed
|
5/2/2019 | IG | Maturities set in Bristol-Myers’ eight-part offering of dollar notes
|
5/2/2019 | BKCVIG | S&P rates Bristol-Myers notes A+
|
5/2/2019 | IGLM | Bristol-Myers gives early results of offers for Celgene notes
|
5/2/2019 | IG | Market Commentary: Morning Commentary: Starbucks, RBS, Florida Power to price; Bristol-Myers offering eyed
|
5/1/2019 | EMHYPFPV | Market Commentary: CNA Financial prices notes; T-Mobile, Bristol-Myers Squibb, Fidelity National eye deals
|
5/1/2019 | IG | Market Commentary: CNA Financial prices notes; T-Mobile, Bristol-Myers Squibb, Fidelity National eye deals
|
5/1/2019 | IG | Bristol-Myers sets investor calls for eight-part offering of notes
|
4/30/2019 | SP | New Issue: JPMorgan prices $3.22 million contingent coupon autocallables linked to Bristol-Myers
|
4/29/2019 | EMHYPFPV | Market Commentary: Norfolk, Lear, Celanese, AEP, Fannie Mae among high-grade issuers; Bristol-Myers eyed
|
4/29/2019 | IG | Market Commentary: Norfolk, Lear, Celanese, AEP, Fannie Mae among high-grade issuers; Bristol-Myers eyed
|
4/29/2019 | IG | Market Commentary: Morning Commentary: Lear, Philip Morris, Norfolk Southern, Celanese notes on tap
|
4/25/2019 | EMHYPFPV | Market Commentary: Omers taps primary; Bristol-Myers deal on horizon; corporate inflows jump; Walmart soft
|
4/25/2019 | IG | Market Commentary: Omers taps primary; Bristol-Myers Squibb deal on horizon; corporate inflows jump; Walmart soft
|
4/25/2019 | IG | Bristol-Myers’ $10 billion-$15 billion bond deal on the horizon to fund Celgene merger
|
4/17/2019 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
4/17/2019 | BKCVIG | S&P rates Bristol-Myers notes A+
|
4/17/2019 | IGLM | Bristol-Myers Squibb launches exchange offer for 19 Celgene notes
|
4/5/2019 | SP | New Issue: UBS prices $750,000 trigger phoenix autocallables linked to Bristol-Myers
|
4/5/2019 | SP | New Issue: UBS prices $450,000 trigger phoenix autocallables linked to Bristol-Myers
|
4/5/2019 | SP | New Issue: UBS prices $375,000 trigger phoenix autocallables linked to Bristol-Myers
|
4/1/2019 | SP | New Issue: JPMorgan sells $5.35 million contingent income autocallables on Bristol-Myers
|
4/1/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/26/2019 | SP | New Issue: UBS prices $1.44 million trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
3/20/2019 | SP | New Issue: UBS prices $400,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
3/18/2019 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/28/2019 | SP | New Issue: Credit Suisse sells $1.14 million contingent coupon autocallable yield notes on stocks
|
2/27/2019 | SP | New Issue: UBS prices $160,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/19/2019 | SP | New Issue: RBC prices $1.61 million 11% callable notes on three pharma stocks
|
2/14/2019 | SP | New Issue: UBS prices $205,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
2/12/2019 | SP | New Issue: UBS prices $379,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
2/12/2019 | SP | New Issue: UBS prices $345,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
2/12/2019 | SP | RBC plans to price 11% callable notes linked to three pharma stocks
|
2/8/2019 | SP | New Issue: HSBC prices $4.31 million phoenix quarterly review notes tied to Bristol-Myers Squibb
|
2/8/2019 | SP | New Issue: UBS prices $505,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/7/2019 | SP | New Issue: UBS prices $300,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
2/6/2019 | SP | New Issue: UBS prices $365,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/6/2019 | SP | New Issue: JPMorgan sells $1.25 million contingent interest autocalls on Bristol-Myers
|
2/4/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/22/2019 | BK | Bristol-Myers Squibb closes $8 billion term loan credit agreement
|
1/7/2019 | CVIG | Fitch puts Bristol-Myers on watch
|
1/3/2019 | CVIG | Moody's may lower Bristol-Myers
|
1/3/2019 | BK | Bristol-Myers Squibb to use debt financing for Celgene acquisition
|
11/29/2018 | SP | New Issue: JPMorgan prices $2.57 million contingent interest autocalls on stocks
|
11/14/2018 | SP | JPMorgan to price 11% contingent interest autocalls on three stocks
|
9/6/2018 | SP | New Issue: JPMorgan prices $1.62 million 10% contingent coupon callables on Bristol-Myers Squibb
|
8/27/2018 | SP | JPMorgan plans 10% contingent income callables tied to Bristol-Myers
|
8/13/2018 | SP | New Issue: UBS prices $325,000 trigger phoenix autocallables linked to Bristol-Myers
|
7/26/2018 | SP | New Issue: RBC prices $2 million 8.05% contingent coupon autocalls on three stocks
|
6/12/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 8.25% potential coupon
|
6/12/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 5% potential coupon
|
6/12/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 4.5% potential coupon
|
6/7/2018 | SP | New Issue: Citigroup sells $3.47 million contingent coupon autocallables on two stocks
|
6/5/2018 | BKCVIG | Fitch affirms Bristol-Myers
|
5/25/2018 | SP | New Issue: JPMorgan sells $1.83 million 11% contingent interest autocalls tied to Bristol-Myers
|
5/24/2018 | SP | New Issue: JPMorgan prices $1.18 million 10.85% contingent coupon callables tied to Bristol-Myers
|
5/23/2018 | SP | New Issue: UBS prices $420,000 trigger phoenix autocallables linked to Bristol-Myers
|
5/22/2018 | SP | New Issue: JPMorgan prices $4.09 million 11.12% contingent interest autocalls tied to three stocks
|
5/14/2018 | SP | JPMorgan plans contingent coupon callable yield notes on Bristol-Myers
|
5/14/2018 | SP | HSBC to price Income Plus CDs tied to stocks with 5% potential coupon
|
5/14/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 10.5% potential coupon
|
5/14/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 5.25% potential coupon
|
5/14/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 8.75% potential coupon
|
5/14/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 5% potential coupon
|
5/11/2018 | SP | New Issue: UBS prices $110,000 trigger phoenix autocallables linked to Bristol-Myers
|
5/11/2018 | SP | New Issue: UBS prices $369,000 trigger phoenix autocallables linked to Bristol-Myers
|
5/8/2018 | SP | New Issue: Credit Suisse sells $4.46 million trigger autocallable contingent yield notes on Bristol-Myers
|
5/8/2018 | SP | New Issue: Morgan Stanley prices $1.85 million contingent income autocalls tied to stocks
|
5/2/2018 | SP | New Issue: Credit Suisse sells $1 million knock-out notes linked to Bristol-Myers
|
5/1/2018 | SP | New Issue: Credit Suisse sells $726,000 contingent coupon autocallable yield notes on three stocks
|
4/23/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 8% potential coupon
|
4/23/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 5% potential coupon
|
4/23/2018 | SP | HSBC to price Income Plus CDs tied to stocks with 5% potential coupon
|
4/23/2018 | SP | HSBC to price Income Plus CDs tied to stocks with 10% potential coupon
|
4/20/2018 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
4/19/2018 | SP | New Issue: UBS prices $127,500 trigger phoenix autocallables linked to Bristol-Myers
|
4/13/2018 | SP | Credit Suisse plans 11%-12% contingent coupon autocalls tied to stocks
|
4/9/2018 | SP | New Issue: Citigroup prices $980,000 autocallable contingent coupon securities linked to stocks
|
4/4/2018 | SP | New Issue: UBS prices $215,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/29/2018 | SP | New Issue: Credit Suisse sells $1.64 million contingent coupon autocallable yield notes on three stocks
|
3/27/2018 | SP | New Issue: UBS prices $510,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/27/2018 | SP | New Issue: JPMorgan sells $1.58 million of 9.1% contingent interest autocalls on Bristol-Myers
|
3/26/2018 | SP | New Issue: UBS prices $300,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/21/2018 | SP | New Issue: Citigroup sells $6.47 million contingent income autocallables on Bristol-Myers
|
3/6/2018 | SP | New Issue: JPMorgan prices $3.84 million 10.5% contingent interest autocalls on Bristol-Myers
|
3/6/2018 | SP | New Issue: JPMorgan prices $1.41 million 9.3% contingent interest autocalls on Bristol-Myers
|
3/2/2018 | SP | New Issue: UBS prices $1.11 million trigger phoenix autocallables linked to Bristol-Myers
|
3/2/2018 | SP | New Issue: Credit Suisse sells $6.52 million contingent coupon autocallable yield notes on stocks
|
3/2/2018 | SP | New Issue: CIBC sells $4.5 million 11.3% contingent rate autocalls tied to stocks
|
3/1/2018 | SP | New Issue: UBS prices $775,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/1/2018 | SP | New Issue: Credit Suisse sells $1.76 million 6.15% airbag autocallable yield notes on Bristol-Myers
|
2/27/2018 | SP | New Issue: GS Finance prices $21.17 million contingent income autocallables on Bristol-Myers
|
2/14/2018 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/13/2018 | SP | New Issue: UBS prices $171,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/9/2018 | SP | CIBC to price contingent coupon autocallable notes on three stocks
|
2/8/2018 | SP | New Issue: Barclays prices $1.77 million 8.25% rate phoenix autocalls on stocks
|
2/7/2018 | BKCVIG | Moody’s changes Bristol-Myers to stable
|
1/31/2018 | SP | New Issue: Citigroup prices $3.57 million contingent coupon autocallables on Bristol-Myers, Merck
|
1/23/2018 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/22/2018 | SP | New Issue: JPMorgan prices $1.25 million 8.35% contingent interest autocalls on Bristol-Myers Squibb
|
1/18/2018 | SP | New Issue: UBS prices $100,000 contingent absolute return autocallables linked to Bristol-Myers
|
1/17/2018 | SP | New Issue: UBS prices $185,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/16/2018 | SP | New Issue: UBS prices $882,500 trigger phoenix autocallables linked to Bristol-Myers
|
1/12/2018 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/10/2018 | SP | Citigroup plans contingent coupon autocallables linked to two stocks
|
12/22/2017 | SP | New Issue: UBS prices $300,000 trigger phoenix autocallables linked to Bristol-Myers
|
12/20/2017 | SP | New Issue: UBS prices $2.01 million airbag autocallable notes on Bristol-Myers
|
12/11/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 11.25% potential coupon
|
12/11/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 5% potential coupon
|
12/11/2017 | SP | HSBC plans Income Plus CDs linked to stocks with 9% potential coupon
|
12/11/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 4.25% potential coupon
|
12/11/2017 | SP | HSBC to price autocallable target income CDs linked to five stocks
|
12/8/2017 | SP | New Issue: UBS prices $360,000 trigger phoenix autocallables linked to Bristol-Myers
|
12/1/2017 | SP | New Issue: Credit Suisse sells $785,000 contingent coupon autocallable yield notes on stocks
|
12/1/2017 | SP | New Issue: Credit Suisse sells $2.25 million contingent 7% autocall reverse converts on Bristol-Myers
|
11/30/2017 | SP | New Issue: HSBC sells $12.79 million trigger autocallable contingent yield notes tied to Bristol-Myers
|
11/29/2017 | SP | New Issue: Morgan Stanley sells $7.59 million contingent income autocallables on Bristol-Myers
|
11/29/2017 | SP | New Issue: UBS prices $775,000 trigger phoenix autocallables linked to Bristol-Myers
|
11/27/2017 | SP | New Issue: RBC sells $1.22 million contingent coupon barrier autocalls on Biogen, Bristol-Myers
|
11/27/2017 | SP | New Issue: JPMorgan sells $4.2 million contingent interest autocallables tied to three stocks
|
11/27/2017 | SP | HSBC to price trigger autocallables tied to Bristol-Myers Squibb
|
11/21/2017 | SP | New Issue: UBS prices $1.06 million trigger phoenix autocallables linked to Bristol-Myers
|
11/20/2017 | SP | New Issue: RBC sells $1.96 million contingent coupon barrier autocalls on Biogen, Bristol-Myers
|
11/16/2017 | SP | New Issue: UBS prices $170,000 trigger phoenix autocallables linked to Bristol-Myers
|
11/15/2017 | SP | New Issue: JPMorgan sells $2.61 million contingent interest autocallables linked to Bristol-Myers
|
11/15/2017 | SPSW | Sales are slow in early part of the month with $231 million; single-stocks volume is up
|
11/14/2017 | SP | New Issue: Morgan Stanley sells $16.01 million contingent income autocalls on Bristol-Myers
|
11/14/2017 | SP | New Issue: Credit Suisse prices $2.59 million 8% autocallable reverse convertibles on four pharma stocks
|
11/13/2017 | SP | HSBC plans Income Plus CDs linked to stocks with 11% potential coupon
|
11/13/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 6.25% potential coupon
|
11/13/2017 | SP | HSBC plans Income Plus CDs linked to stocks with 9% potential coupon
|
11/13/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 4.25% potential coupon
|
11/13/2017 | SP | HSBC to price autocallable target income CDs linked to five stocks
|
11/13/2017 | SP | Morgan Stanley plans contingent income autocallables linked to Bristol
|
11/6/2017 | SP | Morgan Stanley plans contingent income autocallables on Bristol-Myers
|
11/3/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
10/31/2017 | SP | New Issue: UBS prices $625,000 trigger phoenix autocallables linked to Bristol-Myers
|
10/30/2017 | SP | New Issue: UBS prices $359,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
10/27/2017 | SP | New Issue: UBS prices $450,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
10/26/2017 | SP | New Issue: Morgan Stanley sells $3.42 million 5.52% contingent income autocalls on pharma stocks
|
10/26/2017 | SP | New Issue: HSBC sells $1 million 0.5% income plus autocallables tied to five stocks
|
10/20/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
10/16/2017 | SP | HSBC to price autocallable target income CDs linked to five stocks
|
10/16/2017 | SP | HSBC plans Income Plus CDs linked to stocks with 10.5% potential coupon
|
10/16/2017 | SP | HSBC plans Income Plus CDs linked to stocks with 5.75% potential coupon
|
10/16/2017 | SP | HSBC plans Income Plus CDs linked to stocks with 8% potential coupon
|
10/16/2017 | SP | HSBC plans Income Plus CDs linked to stocks with 6.5% potential coupon
|
10/16/2017 | SP | HSBC plans Income Plus CDs linked to stocks with 5% potential coupon
|
10/16/2017 | SP | HSBC plans Income Plus CDs linked to stocks with 3.5% potential coupon
|
10/2/2017 | SP | New Issue: UBS prices $377,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
10/2/2017 | SP | New Issue: UBS prices $565,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
9/28/2017 | SP | New Issue: Citi prices $1.4 million contingent coupon autocallables tied to stocks
|
9/27/2017 | SP | New Issue: RBC sells $150,000 contingent coupon barrier autocallables tied to Amgen, Bristol-Myers
|
9/27/2017 | SP | New Issue: Credit Suisse sells $10.86 million trigger autocallable contingent yield notes on Bristol-Myers
|
9/20/2017 | SP | Credit Suisse to price trigger autocallable notes on Bristol-Myers
|
9/15/2017 | SP | RBC plans two-year contingent coupon barrier autocallables on stocks
|
9/14/2017 | SP | New Issue: JPMorgan prices $1.45 million contingent buffer return enhanced notes tied to stocks
|
9/14/2017 | SP | New Issue: RBC sells $153,000 contingent coupon barrier autocallables on Amgen, Bristol-Myers
|
9/13/2017 | SP | New Issue: JPMorgan sells $1.91 million contingent interest autocallables linked to Bristol-Myers
|
9/11/2017 | SP | BMO Harris plans digital yield generator CDs linked to stock basket
|
9/1/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
9/1/2017 | SP | RBC eyes autocallable contingent coupon barrier notes tied to stocks
|
8/31/2017 | SP | New Issue: UBS prices $460,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/22/2017 | SP | New Issue: UBS prices $1.4 million trigger autocallables linked to Bristol-Myers
|
8/18/2017 | SP | JPMorgan plans digital contingent coupon CDs linked to 10 stocks
|
8/18/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
8/18/2017 | SP | Wells Fargo plans variable annual interest CDs tied to 10 stocks
|
8/17/2017 | SP | New Issue: RBC sells $1.04 million contingent coupon barrier autocallables tied to two stocks
|
8/16/2017 | SP | New Issue: UBS prices $100,000 trigger autocallables linked to Bristol-Myers
|
8/11/2017 | SP | New Issue: Credit Suisse prices $4.3 million contingent income autocallables tied to Bristol-Myers
|
8/8/2017 | SP | New Issue: UBS prices $350,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/7/2017 | SP | RBC eyes autocallable contingent coupon barrier notes tied to stocks
|
7/27/2017 | SP | New Issue: RBC prices $693,000 contingent coupon barrier autocallables on Amgen, Bristol-Myers
|
7/26/2017 | SP | Market Commentary: Wells Fargo’s variable annual interest CDs tied to 10 stocks offer alternative to fixed income
|
7/26/2017 | SP | New Issue: Credit Suisse sells $4.35 million contingent coupon autocallable yield notes on Bristol-Myers
|
7/24/2017 | SP | Wells Fargo plans variable annual interest CDs tied to 10 stocks
|
7/21/2017 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Bristol-Myers
|
7/19/2017 | SP | Credit Suisse plans contingent coupon autocallable yield notes linked to Bristol-Myers
|
7/17/2017 | SP | New Issue: HSBC sells $1.55 million autocallable yield notes tied to three stocks
|
7/14/2017 | SP | RBC plans contingent coupon autocallables on Amgen, Bristol-Myers
|
7/12/2017 | SP | New Issue: UBS prices $140,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
7/10/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
7/10/2017 | SP | New Issue: HSBC sells $3.68 million income plus notes with 5% potential coupon
|
6/26/2017 | SP | New Issue: RBC prices $455,000 contingent coupon autocallables linked to Amgen, Bristol-Myers
|
6/26/2017 | SP | HSBC plans income plus notes on five stocks with 5% potential coupon
|
6/22/2017 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallables linked to Bristol-Myers
|
6/21/2017 | IGLM | Bristol-Myers Squibb gets tenders for $337 million of three series
|
6/20/2017 | IGLM | Bristol-Myers prices tender offer for 5.875%, 6.125%, 6.875% debt
|
6/20/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
6/19/2017 | SP | Wells Fargo plans variable annual interest CDs tied to 10 stocks
|
6/15/2017 | SP | RBC will price autocallable contingent coupon barrier notes on stocks
|
6/14/2017 | IGLM | Bristol-Myers tenders for 5.875% and 6.125% notes, 6.875% debentures
|
6/7/2017 | SP | New Issue: GS Finance sells $645,000 autocallable contingent coupon notes on Bristol-Myers
|
6/5/2017 | SP | New Issue: HSBC sells $2.03 million income plus notes on five stocks with 5% potential coupon
|
6/5/2017 | SP | New Issue: HSBC sells $1.02 million income plus notes with 3.75% potential coupon
|
6/5/2017 | SP | New Issue: HSBC sells $710,000 income plus notes on five stocks with 5% potential coupon
|
5/31/2017 | SP | New Issue: UBS prices $140,000 trigger phoenix autocallables linked to Bristol-Myers
|
5/30/2017 | SP | New Issue: RBC prices $476,000 contingent coupon barrier autocallables on two pharma stocks
|
5/30/2017 | SP | New Issue: Deutsche Bank sells $2.9 million phoenix autocallables tied to Bristol-Myers Squibb
|
5/24/2017 | SP | HSBC plans income plus notes tied to stocks with 1.25%-3.75% coupon
|
5/24/2017 | SP | HSBC plans income plus notes tied to five stocks with 1%-5% coupon
|
5/22/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
5/22/2017 | SP | Wells Fargo plans variable annual interest CDs tied to five stocks
|
5/22/2017 | SP | Wells Fargo plans variable annual interest CDs tied to 10 stocks
|
5/18/2017 | SP | New Issue: Credit Suisse prices $2.75 million 8% autocallable reverse convertibles on Bristol-Myers Squibb
|
5/17/2017 | SP | New Issue: UBS prices $1.85 million trigger autocallables linked to Bristol-Myers
|
5/17/2017 | SP | Deutsche Bank to price phoenix autocallables linked to Bristol-Myers
|
5/11/2017 | SP | New Issue: Citi sells $3.79 million contingent coupon autocallables tied to stocks
|
5/10/2017 | SP | RBC plans autocallable contingent coupon barrier notes on two stocks
|
5/8/2017 | SP | New Issue: RBC prices $1.97 million contingent coupon barrier autocallables tied to two stocks
|
5/8/2017 | SP | New Issue: HSBC sells $1.16 million income plus notes linked to five stocks
|
5/3/2017 | SP | New Issue: UBS prices $100,000 contingent absolute return autocallables linked to Bristol-Myers
|
5/2/2017 | SP | New Issue: JPMorgan prices $26.39 million contingent income autocallables tied to Bristol-Myers
|
5/1/2017 | SP | HSBC plans to price income plus notes linked to five stocks
|
4/26/2017 | SP | New Issue: JPMorgan prices $3.9 million contingent interest autocallables on Bristol-Myers
|
4/25/2017 | SP | New Issue: UBS prices $625,000 trigger phoenix autocallables linked to Bristol-Myers
|
4/21/2017 | SP | JPMorgan plans contingent income autocallables tied to Bristol-Myers
|
4/21/2017 | SP | New Issue: Citigroup sells $3.35 million autocallable contingent coupon securities on two stocks
|
4/20/2017 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
4/20/2017 | SP | Wells Fargo plans variable annual interest CDs tied to five stocks
|
4/20/2017 | SP | Wells Fargo plans variable annual interest CDs linked to five stocks
|
4/19/2017 | SP | JPMorgan eyes autocallable contingent interest notes on Bristol-Myers
|
4/18/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
4/18/2017 | SP | New Issue: Credit Suisse sells $679,000 autocallable yield notes on pharma stocks
|
4/17/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
4/5/2017 | SP | Market Commentary: HSBC’s income plus tied to five stocks with 1.5%-7.8% rate offer high/low structure, protection
|
4/4/2017 | SP | HSBC plans income plus notes tied to five stocks with 1.5%-7.8% coupon
|
3/29/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/28/2017 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/24/2017 | SP | New Issue: UBS prices $145,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/24/2017 | SP | New Issue: UBS prices $590,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/23/2017 | SP | New Issue: UBS prices $610,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/23/2017 | SP | New Issue: UBS prices $920,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/23/2017 | SP | New Issue: UBS prices $530,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/20/2017 | SP | New Issue: UBS prices $170,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
3/17/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/16/2017 | SP | New Issue: JPMorgan prices $1.43 million contingent interest autocallables on Bristol-Myers
|
3/13/2017 | SP | New Issue: UBS prices $105,000 trigger return optimization notes on Bristol-Myers
|
3/13/2017 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/7/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
3/6/2017 | SP | Wells Fargo to price variable annual interest CDs tied to five stocks
|
3/6/2017 | SP | Wells Fargo plans variable annual interest CDs linked to five stocks
|
3/6/2017 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
3/6/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 9.75% potential coupon
|
3/6/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 8.25% potential coupon
|
3/6/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 6.75% potential coupon
|
3/6/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 5.25% potential coupon
|
3/6/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 7.75% potential coupon
|
3/6/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 6.25% potential coupon
|
3/6/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 4.75% potential coupon
|
3/6/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 3.5% potential coupon
|
3/3/2017 | SP | New Issue: UBS prices $99,975 4.26% trigger yield optimization notes linked to Bristol-Myers
|
3/2/2017 | SP | New Issue: UBS prices $914,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/2/2017 | SP | New Issue: UBS prices $530,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/1/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
3/1/2017 | SP | JPMorgan plans contingent interest autocallables linked to Bristol-Myers
|
2/27/2017 | SP | New Issue: UBS prices $414,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
2/27/2017 | IG | Market Commentary: Morning Commentary: Westpac, Moody’s, ConEd, Charles Schwab prep deals; Bristol-Myers softens
|
2/24/2017 | EMHYPFPV | Market Commentary: Fannie Mae, Pfizer sell notes; Bristol-Myers steady; Mizuho, Parker-Hannifin tighten
|
2/24/2017 | IG | Market Commentary: Fannie Mae, Pfizer sell notes; Bristol-Myers steady; Mizuho, Parker-Hannifin tighten
|
2/24/2017 | IG | Market Commentary: Morning Commentary: Pfizer markets 30-year notes; Bristol-Myers improves in secondary market
|
2/23/2017 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/23/2017 | EMHYPFPV | Market Commentary: Danske, Nederlandse Waterschapsbank price; Fannie Mae offers notes; Bristol-Myers steady
|
2/23/2017 | IG | Market Commentary: Danske, Nederlandse Waterschapsbank price; Fannie Mae offers notes; Bristol-Myers steady
|
2/23/2017 | IG | Market Commentary: Morning Commentary: Fannie Mae offers notes; Quebec preps bond deal; Bristol-Myers better
|
2/22/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/22/2017 | SP | New Issue: UBS prices $830,000 contingent absolute return autocallables linked to Bristol-Myers
|
2/22/2017 | EMHYPFPV | Market Commentary: Mizuho, Bristol-Myers, Paccar, Spire tap high-grade primary market; LyondellBasell improves
|
2/22/2017 | IG | Market Commentary: Mizuho, Bristol-Myers, Paccar, Spire tap high-grade primary market; LyondellBasell improves
|
2/22/2017 | IG | New Issue: Bristol-Myers Squibb prices $1.5 billion of two-year, 10-year notes
|
2/22/2017 | CVIG | Fitch: Bristol-Myers notes A-
|
2/22/2017 | CVIG | Moody’s gives Bristol-Myers notes A2
|
2/22/2017 | CVIG | S&P: Bristol-Myers notes A+
|
2/22/2017 | IG | Market Commentary: Morning Commentary: Bristol-Myers, Mizuho, Spire offer high-grade bonds; LyondellBasell firms
|
2/22/2017 | IG | Bristol-Myers to sell two-year, 10-year notes via five bookrunners
|
2/21/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
2/16/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/15/2017 | SP | New Issue: UBS prices $126,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/15/2017 | SP | New Issue: UBS prices $1.85 million trigger autocallables linked to Bristol-Myers
|
2/14/2017 | SP | New Issue: UBS prices $100,000 trigger autocallables linked to Bristol-Myers
|
2/14/2017 | SP | New Issue: UBS prices $1.85 million trigger autocallables linked to Bristol-Myers
|
2/14/2017 | SP | Wells Fargo plans variable annual interest CDs due 2024 on five stocks
|
2/14/2017 | SP | Wells Fargo plans variable annual interest CDs due 2022 on five stocks
|
2/14/2017 | SP | Wells Fargo plans variable annual interest CDs due 2024 on 10 stocks
|
2/13/2017 | CVIG | Moody’s: Bristol-Myers view to negative
|
2/10/2017 | SP | New Issue: Credit Suisse prices $3.65 million knock-out notes on Bristol-Myers
|
2/10/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 10.5% potential coupon
|
2/10/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 9% potential coupon
|
2/10/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 7.5% potential coupon
|
2/10/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 6% potential coupon
|
2/10/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 7.75% potential coupon
|
2/10/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 6.25% potential coupon
|
2/10/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 4.75% potential coupon
|
2/10/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 3.5% potential coupon
|
2/9/2017 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/9/2017 | SP | New Issue: JPMorgan prices $4.14 million contingent interest autocallables tied to Bristol-Myers Squibb
|
2/9/2017 | SP | New Issue: HSBC prices $2.31 million autocallable contingent income barrier notes on stocks
|
2/8/2017 | SP | New Issue: UBS prices $408,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/7/2017 | SP | New Issue: HSBC prices $4.19 million phoenix quarterly review notes tied to Bristol-Myers Squibb
|
2/3/2017 | SP | New Issue: UBS prices $125,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/2/2017 | SP | New Issue: UBS prices $340,000 return optimization securities on Bristol-Myers
|
2/2/2017 | SP | New Issue: RBC prices $4.05 million direct investment notes tied to 20 stocks
|
2/1/2017 | SP | Credit Suisse plans knock-out notes linked to Bristol-Myers Squibb
|
2/1/2017 | SP | New Issue: UBS prices $205,000 trigger phoenix autocallables linked to Bristol-Myers
|
2/1/2017 | SP | HSBC plans autocallable contingent income barrier notes tied to stocks
|
1/26/2017 | SP | HSBC plans phoenix quarterly review notes tied to Bristol-Myers Squibb
|
1/25/2017 | SP | New Issue: UBS prices $706,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/24/2017 | SP | New Issue: UBS prices $405,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/23/2017 | SP | New Issue: UBS prices $157,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
1/20/2017 | SP | New Issue: UBS prices $305,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/20/2017 | SP | New Issue: UBS prices $510,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/20/2017 | SP | New Issue: UBS prices $175,000 return optimization securities on Bristol-Myers
|
1/19/2017 | SP | New Issue: UBS prices $300,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/17/2017 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/12/2017 | SP | New Issue: UBS prices $675,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/10/2017 | SP | New Issue: UBS prices $162,500 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
1/9/2017 | SP | Wells Fargo plans variable annual interest CDs due 2024 on 10 stocks
|
1/9/2017 | SP | Wells Fargo plans variable annual interest CDs due 2024 on five stocks
|
1/9/2017 | SP | Wells Fargo plans variable annual interest CDs due 2022 on five stocks
|
1/9/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 10% potential coupon
|
1/9/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 8.5% potential coupon
|
1/9/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 7% potential coupon
|
1/9/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 5.5% potential coupon
|
1/9/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 7.75% potential coupon
|
1/9/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 6.25% potential coupon
|
1/9/2017 | SP | HSBC plans Income Plus CDs tied to stocks with 4.75% potential coupon
|
1/9/2017 | SP | RBC plans direct investment notes linked to basket of 20 stocks
|
1/6/2017 | SP | New Issue: UBS prices $179,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
1/6/2017 | SP | New Issue: UBS prices $235,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
1/6/2017 | SP | New Issue: UBS prices $241,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
1/5/2017 | SP | New Issue: UBS prices $360,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/5/2017 | SP | New Issue: UBS prices $130,000 trigger phoenix autocallables linked to Bristol-Myers
|
1/3/2017 | SP | New Issue: UBS prices $364,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
12/29/2016 | SP | New Issue: RBC prices $2 million contingent coupon barrier autocallables on two pharma stocks
|
12/27/2016 | SP | New Issue: UBS prices $120,000 trigger phoenix autocallables linked to Bristol-Myers
|
12/23/2016 | SP | New Issue: UBS prices $1.18 million trigger phoenix autocallables linked to Bristol-Myers
|
12/23/2016 | SP | New Issue: UBS prices $850,000 trigger phoenix autocallables linked to Bristol-Myers
|
12/22/2016 | SP | New Issue: UBS prices $99,950 4.09% trigger yield optimization notes linked to Bristol-Myers
|
12/16/2016 | SP | Wells Fargo to price variable annual interest CDs linked to 10 stocks
|
12/16/2016 | SP | Wells Fargo eyes variable annual interest CDs due 2023 on five stocks
|
12/16/2016 | SP | Wells Fargo eyes variable annual interest CDs due 2021 on five stocks
|
12/15/2016 | SP | New Issue: UBS prices $110,000 trigger phoenix autocallables linked to Bristol-Myers
|
12/13/2016 | SP | RBC plans autocallables with memory coupon linked to pharma stocks
|
12/12/2016 | SP | JPMorgan plans contingent interest autocallables tied to Bristol-Myers
|
12/9/2016 | SP | New Issue: BofA Finance prices $1.43 million contingent income autocallables linked to pharma stocks
|
12/7/2016 | SP | New Issue: UBS prices $100,000 contingent absolute return autocallables linked to Bristol-Myers
|
12/5/2016 | SP | New Issue: Credit Suisse sells $1.06 million autocallalble coupon buffered notes on Bristol-Myers Squibb
|
11/10/2016 | SP | Wells Fargo to price variable annual interest CDs linked to 10 stocks
|
11/10/2016 | SP | Wells Fargo eyes variable annual interest CDs due 2023 on five stocks
|
11/9/2016 | SP | New Issue: Credit Suisse sells $920,000 contingent coupon autocallable yield notes on Bristol-Myers
|
11/8/2016 | SP | Wells Fargo to price variable annual interest CDs tied to five stocks
|
11/8/2016 | SP | New Issue: UBS prices $576,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
11/7/2016 | SP | HSBC plans to price seven-year Rate Builder CDs linked to 10 stocks
|
11/7/2016 | SP | HSBC plans to price five-year Rate Builder CDs linked to 10 stocks
|
11/7/2016 | SP | New Issue: JPMorgan prices $1.09 million 7.5% autocallable yield notes on Bristol-Myers
|
11/4/2016 | SP | New Issue: UBS prices $100,000 trigger autocallables linked to Bristol-Myers
|
11/3/2016 | SP | Credit Suisse plans contingent coupon autocallables on Bristol-Myers
|
11/1/2016 | SP | New Issue: UBS prices $650,000 contingent absolute return autocallable optimization securities linked to Bristol-Myers
|
10/26/2016 | SP | New Issue: UBS prices $145,000 trigger phoenix autocallables linked to Bristol-Myers
|
10/26/2016 | SP | New Issue: JPMorgan prices $1 million contingent buffered notes linked to Bristol-Myers
|
10/26/2016 | SPSW | Structured products agents sell $317 million amid flat stock market, election, interest rate views
|
10/25/2016 | SP | New Issue: Barclays prices $1.34 million phoenix autocallables tied to Bristol-Myers
|
10/25/2016 | SP | New Issue: JPMorgan sells $14.69 million contingent income autocallable notes on Bristol-Myers
|
10/24/2016 | SP | New Issue: UBS prices $171,500 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
10/20/2016 | SP | New Issue: UBS prices $100,000 contingent absolute return autocallables linked to Bristol-Myers
|
10/20/2016 | SP | New Issue: JPMorgan prices $3 million contingent interest autocallables tied to two stocks
|
10/19/2016 | SP | New Issue: UBS prices $625,000 trigger phoenix autocallables linked to Bristol-Myers
|
10/19/2016 | SP | Barclays plans phoenix autocallables linked to Bristol-Myers Squibb
|
10/17/2016 | SP | New Issue: UBS prices $626,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
10/14/2016 | SP | JPMorgan plans 7% yield autocallables linked to Bristol-Myers Squibb
|
10/14/2016 | SP | New Issue: Credit Suisse sells $1.24 million contingent coupon autocallable yield notes on Bristol-Myers
|
10/14/2016 | SP | New Issue: Credit Suisse sells $1.07 million contingent coupon autocallables on Bristol-Myers
|
10/13/2016 | SP | JPMorgan plans contingent income autocallable notes on Bristol-Myers
|
10/11/2016 | SP | New Issue: Barclays sells $845,000 of contingent interest autocallables on Bristol-Myers
|
10/11/2016 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
10/10/2016 | SP | Wells Fargo to price variable annual interest CDs linked to 10 stocks
|
10/10/2016 | SP | Wells Fargo to price variable annual interest CDs tied to five stocks
|
10/10/2016 | SP | Wells Fargo plans variable annual interest CDs linked to five stocks
|
10/10/2016 | SP | HSBC plans to price seven-year Rate Builder CDs linked to 10 stocks
|
10/10/2016 | SP | HSBC plans to price five-year Rate Builder CDs linked to 10 stocks
|
10/7/2016 | SP | New Issue: UBS prices $255,000 airbag yield optimization notes on Bristol-Myers
|
10/5/2016 | SP | Barclays plans autocallable contingent interest notes on Bristol-Myers
|
10/4/2016 | SP | Credit Suisse plans contingent coupon autocallables linked to Bristol
|
10/4/2016 | SP | New Issue: UBS prices $160,000 airbag yield optimization notes on Bristol-Myers
|
10/3/2016 | SP | New Issue: RBC prices $948,000 direct investment notes tied to basket of 25 stocks
|
9/30/2016 | SP | New Issue: UBS prices $155,000 airbag yield optimization notes on Bristol-Myers
|
9/30/2016 | SP | New Issue: HSBC prices $389,000 income plus notes linked to five stocks
|
9/30/2016 | SP | New Issue: HSBC prices $1.41 million income plus notes linked to five stocks
|
9/29/2016 | SP | New Issue: UBS prices $160,000 airbag yield optimization notes on Bristol-Myers
|
9/27/2016 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
9/27/2016 | SP | New Issue: UBS prices $130,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
9/27/2016 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
9/27/2016 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
9/23/2016 | SP | HSBC plans income plus notes on five stocks with 0.5% minimum coupon
|
9/23/2016 | SP | HSBC plans income plus notes on five stocks with 1% minimum coupon
|
9/19/2016 | SP | Wells Fargo plans variable annual interest CDs linked to five stocks
|
9/19/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
9/16/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
9/16/2016 | SP | New Issue: JPMorgan prices $3.01 million contingent interest autocallables on Bristol-Myers
|
9/13/2016 | SP | New Issue: Credit Suisse prices $925,000 dual directional knock-out notes linked to Bristol-Myers
|
9/12/2016 | SP | HSBC plans to price seven-year Rate Builder CDs linked to 10 stocks
|
9/12/2016 | SP | HSBC plans to price five-year Rate Builder CDs linked to 10 stocks
|
9/7/2016 | SP | Credit Suisse plans dual directional capped knock-out notes on Bristol-Myers
|
9/1/2016 | SP | New Issue: UBS prices $115,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/31/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/31/2016 | SP | New Issue: HSBC prices $1.7 million seven-year income plus notes tied to five stocks
|
8/31/2016 | SP | New Issue: HSBC prices $441,000 seven-year income plus notes tied to five stocks
|
8/29/2016 | SP | New Issue: JPMorgan sells $641,000 autocallable contingent interest notes tied to three stocks
|
8/26/2016 | SP | New Issue: UBS prices $190,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/26/2016 | SP | New Issue: UBS prices $335,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/26/2016 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/26/2016 | SP | New Issue: UBS prices $520,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/26/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/25/2016 | SP | RBC to price direct investment notes linked to basket of 25 stocks
|
8/25/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/25/2016 | SP | New Issue: UBS prices $215,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/25/2016 | SP | New Issue: RBC prices $2 million contingent coupon barrier autocallables tied to two stocks
|
8/24/2016 | SP | New Issue: UBS prices $500,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/23/2016 | SP | New Issue: JPMorgan prices $13.04 million trigger autocallables linked to Bristol-Myers Squibb
|
8/23/2016 | SP | New Issue: JPMorgan prices $5.29 million contingent interest autocallables linked to four stocks
|
8/17/2016 | SP | JPMorgan plans trigger autocallable contingent yield notes tied to Bristol-Myers Squibb
|
8/16/2016 | SP | New Issue: JPMorgan prices $5.32 million contingent interest autocallables linked to Bristol-Myers Squibb
|
8/12/2016 | SP | JPMorgan plans contingent interest autocallables tied to three stocks
|
8/12/2016 | SP | New Issue: UBS prices $155,000 trigger phoenix autocallable optimizations linked to Bristol-Myers
|
8/11/2016 | SP | New Issue: UBS prices $125,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/10/2016 | SP | New Issue: UBS prices $500,000 trigger phoenix autocallables linked to Bristol-Myers
|
8/10/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
8/9/2016 | SP | JPMorgan plans autocallable contingent interest notes on Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $675,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $167,945 6.02% trigger yield optimization notes linked to Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $265,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $354,937 4.26% trigger yield optimization notes linked to Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $575,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $510,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $1.04 million trigger autocallables linked to Bristol-Myers
|
8/9/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers Squibb
|
8/9/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers Squibb
|
8/8/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Bristol-Myers Squibb
|
8/8/2016 | SP | New Issue: JPMorgan sells $980,000 autocallable contingent interest notes on three stocks
|
8/8/2016 | SP | HSBC plans to price seven-year Rate Builder CDs linked to 10 stocks
|
8/8/2016 | SP | HSBC plans to price five-year Rate Builder CDs linked to 10 stocks
|
8/4/2016 | SP | HSBC plans income plus notes on five stocks with 0.5% minimum coupon
|
8/4/2016 | SP | HSBC plans income plus notes on five stocks with 1% minimum coupon
|
8/3/2016 | SP | JPMorgan plans contingent interest autocallables tied to four stocks
|
8/2/2016 | SP | New Issue: HSBC prices $929,000 seven-year income plus notes tied to five stocks
|
8/2/2016 | SP | New Issue: HSBC prices $664,000 seven-year income plus notes tied to five stocks
|
7/28/2016 | SP | JPMorgan plans contingent interest autocallables tied to three stocks
|
7/19/2016 | SP | New Issue: JPMorgan sells $2 million contingent coupon callable yield notes on Bristol-Myers
|
7/14/2016 | SP | JPMorgan plans contingent coupon callable notes on Bristol-Myers Squibb
|
7/13/2016 | SP | Market Commentary: HSBC’s notes tied to five stocks with 5.5% potential coupon target conservative income seekers
|
7/12/2016 | SP | HSBC plans income plus notes on five stocks with 8% potential coupon
|
7/12/2016 | SP | HSBC plans income plus notes on five stocks with 5.5% potential coupon
|
7/11/2016 | SP | Goldman Sachs plans to price variable coupon CDs linked to 10 stocks
|
7/11/2016 | SP | Goldman Sachs plans variable coupon CDs due 2026 linked to 10 stocks
|
7/11/2016 | SP | Goldman Sachs plans variable coupon CDs due 2023 linked to 10 stocks
|
7/11/2016 | SP | Goldman Sachs plans variable coupon CDs due 2021 linked to 10 stocks
|
7/11/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
7/11/2016 | SP | HSBC plans to price seven-year Rate Builder CDs linked to 10 stocks
|
7/11/2016 | SP | HSBC plans to price five-year Rate Builder CDs linked to 10 stocks
|
6/13/2016 | SP | HSBC plans to price seven-year Rate Builder CDs linked to 10 stocks
|
6/13/2016 | SP | HSBC plans to price five-year Rate Builder CDs linked to 10 stocks
|
6/13/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
6/13/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 6.75% potential coupon
|
6/13/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 5.5% potential coupon
|
6/13/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 4.25% potential coupon
|
6/13/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 3% potential coupon
|
6/13/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 5% potential coupon
|
6/13/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 3.75% potential coupon
|
6/13/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 2.5% potential coupon
|
6/13/2016 | SP | Goldman Sachs Bank to price variable-coupon CDs due 2021 on 10 stocks
|
6/13/2016 | SP | Goldman Sachs Bank plans variable-coupon CDs due 2023 on 10 stocks
|
6/13/2016 | SP | Goldman Sachs Bank to price variable-coupon CDs due 2026 on 10 stocks
|
6/13/2016 | SP | Goldman Sachs Bank to price variable-coupon CDs due 2023 on 10 stocks
|
5/26/2016 | SP | New Issue: Morgan Stanley sells $3.46 million contingent income autocallables on Bristol-Myers
|
5/17/2016 | SP | New Issue: JPMorgan prices $2 million callable yield notes on Bristol-Myers Squibb
|
5/13/2016 | SP | Morgan Stanley plans contingent income autocallables on Bristol-Myers
|
5/10/2016 | SP | HSBC plans 0.25%-3.5% five-year Rate Builder CDs linked to 10 stocks
|
5/10/2016 | SP | HSBC plans 0.3%-5% seven-year Rate Builder CDs linked to 10 stocks
|
5/9/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
5/9/2016 | SP | Goldman Sachs plans variable-coupon CDs due 2023 tied to stock basket
|
5/9/2016 | SP | Goldman Sachs Bank to price variable-coupon CDs due 2023 on 10 stocks
|
5/9/2016 | SP | Goldman Sachs plans variable-coupon CDs due 2023 linked to 10 stocks
|
5/9/2016 | SP | Goldman Sachs Bank plans variable-coupon CDs due 2020 on 10 stocks
|
5/9/2016 | SP | Goldman Sachs Bank plans variable-coupon CDs due 2026 on 10 stocks
|
5/9/2016 | SP | Goldman Sachs Bank plans variable-coupon CDs due 2021 on 10 stocks
|
5/9/2016 | SP | HSBC plans seven-year Income Plus CDs on stocks with 1% coupon floor
|
5/9/2016 | SP | HSBC plans Income Plus CDs linked to stocks with 0.25% coupon floor
|
5/9/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 0.25% minimum coupon
|
5/9/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 0.5% minimum coupon
|
5/9/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 0.75% minimum coupon
|
5/5/2016 | SP | Bank of the West plans contingent variable-income CDs on 10 stocks
|
4/11/2016 | SP | Goldman Sachs to price variable coupon CDs linked to stock basket
|
4/11/2016 | SP | Goldman Sachs plans variable coupon CDs due 2023 linked to 10 stocks
|
4/11/2016 | SP | Goldman Sachs plans variable coupon CDs due 2021 linked to 10 stocks
|
4/11/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 8% potential coupon
|
4/11/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 6.5% potential coupon
|
4/11/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 4% potential coupon
|
4/11/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 6% potential coupon
|
4/11/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 4.5% potential coupon
|
4/11/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
4/4/2016 | SP | New Issue: HSBC prices $1.05 million seven-year income plus notes on five stocks
|
3/24/2016 | SP | New Issue: GS Finance prices $1.95 million autocallable contingent coupon notes on Bristol-Myers
|
3/10/2016 | SP | Goldman Sachs plans variable coupon CDs due 2023 linked to 10 stocks
|
3/10/2016 | SP | Goldman Sachs to price variable coupon CDs tied to 10 stocks
|
3/10/2016 | SP | Goldman Sachs plans to price variable coupon CDs linked to 10 stocks
|
3/8/2016 | SP | New Issue: Barclays prices $1.1 million 0.125% synthetic convertibles linked to Bristol-Myers
|
3/8/2016 | SP | New Issue: Barclays prices $1.77 million trigger phoenix autocallables on Bristol-Myers Squibb
|
3/8/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
2/26/2016 | SP | HSBC plans income plus notes on five stocks with 6% potential coupon
|
2/26/2016 | SP | New Issue: HSBC prices $1.55 million seven-year income plus notes on five stocks
|
2/11/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
2/9/2016 | SP | Goldman Sachs plans to price variable coupon CDs linked to 10 stocks
|
2/9/2016 | SP | Goldman Sachs plans variable coupon CDs due 2023 linked to 10 stocks
|
2/9/2016 | SP | Goldman Sachs plans variable coupon CDs due 2021 linked to 10 stocks
|
2/1/2016 | SP | HSBC plans income plus notes on stocks with 6.25% potential coupon
|
1/29/2016 | SP | New Issue: HSBC prices $890,000 seven-year income plus notes linked to five stocks
|
1/26/2016 | SP | New Issue: JPMorgan prices $766,900 contingent income autocallables linked to Bristol-Myers Squibb
|
1/20/2016 | SP | New Issue: JPMorgan sells $845,000 autocallable contingent notes on Bristol-Myers
|
1/14/2016 | SP | JPMorgan plans contingent income autocallables linked to Bristol-Myers
|
1/14/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
1/14/2016 | SP | Goldman Sachs plans variable coupon CDs due 2023 linked to 10 stocks
|
1/14/2016 | SP | Goldman Sachs plans variable coupon CDs due 2021 linked to 10 stocks
|
1/13/2016 | SP | HSBC plans income plus notes on five stocks with 7% potential coupon
|
1/13/2016 | SP | New Issue: JPMorgan prices $845,000 contingent interest autocallables on Bristol-Myers Squibb
|
1/13/2016 | SP | JPMorgan plans contingent interest autocallables tied to Bristol-Myers
|
1/8/2016 | SP | Barclays plans CDs linked to 10 common stocks with 1% minimum coupon
|
1/8/2016 | SP | Barclays to price CDs tied to 10 common stocks with 0.5% minimum coupon
|
1/8/2016 | SP | Barclays plans CDs linked to 10 common stocks with 0.5% minimum coupon
|
1/8/2016 | SP | Barclays plans CDs linked to 10 common stocks with 0.25% minimum coupon
|
1/8/2016 | SP | Barclays plans CDs due 2023 linked to basket of five common stocks
|
1/8/2016 | SP | Barclays plans CDs due 2022 linked to basket of five common stocks
|
1/8/2016 | SP | Barclays plans CDs due 2021 linked to basket of five common stocks
|
1/5/2016 | SP | JPMorgan plans contingent interest autocallables tied to Bristol-Myers
|
12/31/2015 | SP | New Issue: JPMorgan prices $665,000 contingent interest autocallables on Bristol-Myers Squibb
|
12/16/2015 | SP | JPMorgan plans contingent interest autocallables linked to Bristol-Myers
|
12/9/2015 | SP | New Issue: Morgan Stanley prices $1.79 million contingent income autocallables linked to Bristol-Myers
|
12/2/2015 | SP | Morgan Stanley plans contingent income autocallables on Bristol-Myers
|
11/9/2015 | SP | New Issue: RBC prices $1.2 million trigger phoenix autocallables on Bristol-Myers, Eli Lilly
|
10/16/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
10/16/2015 | SP | Barclays Bank Delaware plans three-year CDs linked to 10 stocks
|
10/16/2015 | SP | Barclays Bank Delaware plans five-year CDs linked to 10 stocks
|
10/16/2015 | SP | Barclays Bank Delaware plans six-year CDs linked to 10 stocks
|
10/16/2015 | SP | Barclays Bank Delaware plans CDs due 2022 linked to 10 stocks
|
10/16/2015 | SP | Barclays Bank Delaware plans seven-year CDs linked to 10 stocks
|
10/16/2015 | SP | Barclays Bank Delaware to price three-year CDs linked to five stocks
|
10/16/2015 | SP | Barclays Bank Delaware to price five-year CDs linked to five stocks
|
10/16/2015 | SP | Barclays Bank Delaware to price six-year CDs linked to five stocks
|
10/16/2015 | SP | Barclays Bank Delaware to price seven-year CDs linked to five stocks
|
10/15/2015 | SP | Goldman Sachs plans variable coupon CDs due 2022 linked to 10 stocks
|
10/15/2015 | SP | Goldman Sachs plans variable coupon CDs due 2020 linked to 10 stocks
|
10/8/2015 | SP | New Issue: Credit Suisse prices $450,000 contingent coupon autocallables linked to stocks
|
10/2/2015 | SP | Bank of the West plans seven-year income CDs linked to 10 stocks
|
9/23/2015 | SP | New Issue: UBS prices $3.36 million trigger phoenix autocallables linked to Bristol-Myers Squibb
|
9/16/2015 | SP | UBS plans trigger phoenix autocallables linked to Bristol-Myers Squibb
|
9/11/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
9/11/2015 | SP | New Issue: JPMorgan prices $1 million contingent buffered notes tied to 11 stocks
|
9/10/2015 | SP | New Issue: Deutsche Bank prices $180,623 call warrants linked to 11 stocks
|
9/10/2015 | SP | New Issue: Deutsche Bank prices $5.96 million knock-out notes on stock basket
|
9/8/2015 | SP | New Issue: Deutsche Bank prices $1.29 million knock-out notes on stock basket
|
9/3/2015 | SP | New Issue: HSBC prices $4.74 million contingent income autocallables tied to Bristol-Myers
|
8/28/2015 | SP | New Issue: Deutsche Bank prices $4.76 million phoenix autocallables on Bristol-Myers Squibb
|
8/25/2015 | SP | JPMorgan to price contingent interest autocallables on Bristol-Myers
|
8/25/2015 | SP | JPMorgan plans autocallable contingent interest notes on Bristol-Myers
|
8/21/2015 | SP | HSBC plans contingent income autocallable notes tied to Bristol-Myers
|
8/18/2015 | SP | Deutsche Bank plans phoenix autocallables tied to Bristol-Myers Squibb
|
8/13/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
8/12/2015 | SP | Barclays plans CDs due 2022 tied to 10 stocks with 0.5% minimum coupon
|
8/12/2015 | SP | Barclays plans CDs due 2022 tied to 10 stocks with 1.25% minimum coupon
|
8/12/2015 | SP | Barclays plans CDs due 2020 tied to 10 stocks with 0.75% minimum coupon
|
8/12/2015 | SP | Barclays plans CDs due 2018 tied to 10 stocks with 0.5% minimum coupon
|
8/12/2015 | SP | Barclays Bank Delaware to price three-year CDs linked to five stocks
|
7/16/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
6/10/2015 | SP | JPMorgan plans contingent interest autocallables tied to Bristol-Myers
|
6/2/2015 | EULM | Bristol-Myers to redeem 4.625% senior notes at €1,291.25 per €1,000
|
5/27/2015 | IGLM | Bristol-Myers wraps oversubscribed tender offer for $500 million notes
|
5/12/2015 | SP | New Issue: JPMorgan prices $13.89 million contingent income autocallables linked to Bristol-Myers
|
5/12/2015 | IGLM | Bristol-Myers increases tender to $500 million, gives early results
|
5/5/2015 | EULM | Bristol-Myers calls all 4.375% notes due 2016, 4.625% notes due 2021
|
5/1/2015 | SP | JPMorgan plans contingent income autocallables linked to Bristol-Myers
|
4/30/2015 | CVIG | Fitch: Bristol-Myers bond A-
|
4/29/2015 | EULM | Bristol-Myers to redeem €1 billion senior notes via new notes offering
|
4/29/2015 | CVIG | S&P: Bistol-Meyers notes A+
|
4/29/2015 | CVIG | Moody’s rates Bristol-Myers notes A2
|
4/28/2015 | IGLM | Bristol-Myers tenders for up to $400 million of four series of notes
|
2/13/2015 | SP | New Issue: JPMorgan prices $1 million digital notes linked to Bristol-Myers
|
2/10/2015 | SP | New Issue: Barclays prices $2.53 million callable yield notes linked to Bristol-Myers Squibb
|
2/6/2015 | SP | JPMorgan plans digital contingent coupon CDs linked to stock basket
|
2/5/2015 | SP | Barclays plans 8% callable yield notes linked to Bristol-Myers Squibb
|
12/18/2014 | SP | New Issue: UBS prices $520,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
12/11/2014 | CVIG | Fitch lifts Bristol-Myers view to stable
|
12/5/2014 | SP | New Issue: HSBC prices $1.39 million phoenix quarterly review notes tied to Bristol-Myers Squibb
|
12/2/2014 | SP | HSBC plans phoenix quarterly review notes tied to Bristol-Myers Squibb
|
10/27/2014 | SP | Morgan Stanley plans contingent income autocallable securities linked to Bristol-Myers Squibb
|
10/8/2014 | SP | New Issue: Barclays prices $975,000 phoenix autocallable notes on Bristol-Myers Squibb
|
10/2/2014 | SP | Barclays plans phoenix autocallable notes tied to Bristol-Myers Squibb
|
10/2/2014 | SP | New Issue: Morgan Stanley prices $1.65 million return enhanced notes on Bristol-Myers Squibb
|
9/26/2014 | SP | New Issue: RBC prices $1.47 million trigger phoenix autocallables on three stocks
|
9/24/2014 | SP | New Issue: Morgan Stanley prices $940,000 return enhanced notes linked to Bristol-Myers Squibb
|
9/23/2014 | SP | New Issue: RBC prices $1.47 million phoenix autocallables on Bristol-Myers Squibb
|
9/18/2014 | SP | Morgan Stanley plans return enhanced notes on Bristol-Myers Squibb
|
9/17/2014 | SP | New Issue: Deutsche Bank prices $4.34 million trigger phoenix autocallables on Bristol-Myers Squibb
|
9/16/2014 | SP | RBC plans to price phoenix autocallable notes on Bristol-Myers Squibb
|
9/10/2014 | SP | Deutsche Bank plans trigger phoenix autocallables on Bristol-Myers
|
8/27/2014 | SP | New Issue: HSBC prices $404,000 income plus notes on stock basket with 1% minimum coupon
|
8/4/2014 | SP | HSBC plans income plus notes on stock basket with 1% minimum coupon
|
7/15/2014 | SP | New Issue: Credit Suisse prices $965,000 return enhanced notes on Bristol-Myers
|
7/14/2014 | SP | Bank of the West plans seven-year income CDs linked to stock basket
|
7/9/2014 | SP | JPMorgan plans to price return notes linked to basket of 16 stocks
|
7/8/2014 | SP | Credit Suisse plans return enhanced notes on Bristol-Myers Squibb
|
7/7/2014 | SP | New Issue: UBS prices $3.52 million trigger phoenix autocallables linked to Bristol-Myers Squibb
|
7/1/2014 | SP | UBS plans five-year trigger phoenix autocallables tied to Bristol-Myers
|
6/27/2014 | SP | New Issue: HSBC prices $971,000 income plus notes linked to five stocks with 1% minimum coupon
|
6/24/2014 | SP | New Issue: RBC prices $1.67 million trigger phoenix autocallables on three stocks
|
6/11/2014 | SP | Bank of the West plans seven-year income CDs linked to stock basket
|
6/11/2014 | SPSW | Volume for year grows 13% to $18.47 billion, but market participants brace for summer slowdown
|
6/9/2014 | SP | New Issue: Barclays prices $11.88 million phoenix autocallables linked to Bristol-Myers Squibb
|
6/4/2014 | SP | New Issue: Barclays prices $9.55 million contingent income autocallables linked to Bristol-Myers
|
6/4/2014 | SP | New Issue: UBS prices $500,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
6/4/2014 | SP | HSBC plans income plus notes on stock basket with 1% minimum coupon
|
5/30/2014 | SP | New Issue: UBS prices $4.5 million trigger phoenix autocallables on three stocks
|
5/28/2014 | SP | New Issue: HSBC prices $2.09 million income plus notes linked to five stocks
|
5/22/2014 | SP | Barclays plans contingent income autocallables linked to Bristol-Myers
|
5/20/2014 | SP | New Issue: Barclays prices $3.86 million callable contingent coupon notes tied to Bristol-Myers Squibb
|
5/16/2014 | SP | Bank of the West plans seven-year income CDs linked to stock basket
|
4/29/2014 | SP | New Issue: Morgan Stanley prices $10.1 million contingent income autocallables linked to Bristol-Myers
|
4/25/2014 | SP | New Issue: HSBC prices $1.34 million income plus notes linked to five stocks with 1% minimum coupon
|
4/21/2014 | SP | Morgan Stanley plans contingent income autocallables linked to Bristol-Myers Squibb
|
4/17/2014 | SP | Barclays plans callable contingent coupon notes tied to Bristol-Myers
|
4/3/2014 | SP | HSBC plans income plus notes on stocks with 1% minimum coupon
|
3/28/2014 | SP | New Issue: HSBC prices $905,000 leveraged contingent buffered enhanced notes on Bristol-Myers
|
3/12/2014 | SP | New Issue: UBS prices $305,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
3/11/2014 | SP | New Issue: HSBC prices $7 million return enhanced notes linked to three stocks
|
3/5/2014 | SP | New Issue: HSBC prices $675,000 return enhanced notes linked to three stocks
|
3/3/2014 | SP | HSBC plans income plus notes on stock basket with 1% minimum coupon
|
2/27/2014 | SP | New Issue: HSBC prices $2.03 million return enhanced notes linked to three stocks
|
2/26/2014 | SP | HSBC plans three-year return enhanced notes linked to three stocks
|
2/26/2014 | SP | New Issue: JPMorgan sells $1.09 million autocallable contingent interest notes on Bristol-Myers
|
2/25/2014 | SP | New Issue: HSBC prices $11.89 million one-year contingent income autocallables tied to Bristol-Myers
|
2/25/2014 | SP | New Issue: HSBC prices $1.06 million income plus notes linked to five stocks with 1% minimum coupon
|
2/24/2014 | SP | New Issue: HSBC prices $1.7 million return enhanced notes linked to pharma stocks
|
2/20/2014 | SP | HSBC plans three-year return enhanced notes linked to three stocks
|
2/20/2014 | SP | New Issue: HSBC prices $1.1 million knock-out buffer notes linked to basket of three stocks
|
2/20/2014 | SP | New Issue: HSBC prices $2.69 million return enhanced notes linked to three stocks
|
2/19/2014 | SP | JPMorgan plans capped return enhanced autocallables on Bristol-Myers
|
2/19/2014 | SP | New Issue: JPMorgan sells $1.66 million autocallable contingent interest notes on Bristol-Myers
|
2/19/2014 | SP | JPMorgan plans autocallable contingent interest notes on Bristol-Myers
|
2/14/2014 | SP | HSBC plans one-year contingent income autocallables on Bristol-Myers
|
2/13/2014 | SP | HSBC to price knock-out buffer notes tied to basket of three stocks
|
2/11/2014 | SP | New Issue: Barclays prices $2.62 million phoenix autocallables on Bristol-Myers
|
2/11/2014 | SP | New Issue: Deutsche Bank prices $445,000 return enhanced notes linked to pharma stocks
|
2/11/2014 | SP | HSBC plans three-year return enhanced notes linked to three stocks
|
2/11/2014 | SP | JPMorgan plans autocallable contingent interest notes on Bristol-Myers
|
2/5/2014 | SP | New Issue: Credit Suisse prices $4.42 million contingent coupon autocallables on Bristol-Myers
|
2/5/2014 | SP | New Issue: Deutsche Bank prices $1.26 million knock-out notes linked to three stocks
|
2/5/2014 | SP | New Issue: Deutsche Bank prices $4.23 million knock-out notes tied to three stocks
|
2/5/2014 | SP | Barclays plans to price phoenix autocallables linked to Bristol-Myers
|
2/5/2014 | SP | HSBC plans income plus notes on stock basket with 1% minimum coupon
|
2/4/2014 | SP | New Issue: Deutsche Bank prices $3.42 million return enhanced notes linked to pharma stocks
|
1/31/2014 | IGLM | Bristol-Myers to redeem $582.06 million 5.45% notes due 2018
|
1/31/2014 | SP | New Issue: Barclays prices $1.18 million 9% callable yield notes on Bristol-Myers
|
1/29/2014 | SP | Deutsche Bank plans knock-out notes tied to basket of three stocks
|
1/28/2014 | SP | Credit Suisse plans contingent coupon autocallables on Bristol-Myers
|
12/23/2013 | CVIG | Fitch: Bristol-Myers view negative
|
12/20/2013 | SP | New Issue: Barclays prices $1.24 million 8.05% callable yield notes linked to Bristol-Myers
|
12/9/2013 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallable optimization securities linked to Bristol-Myers
|
12/6/2013 | SP | HSBC plans income plus CDs on five stocks with 1% minimum coupon
|
12/6/2013 | SP | HSBC plans income plus CDs on five stocks with 0.25% minimum coupon
|
12/6/2013 | SP | HSBC plans income plus CDs on five stocks with 0.5% minimum coupon
|
12/6/2013 | SP | HSBC plans income plus CDs on five stocks with 0.75% minimum coupon
|
10/25/2013 | IG | Market Commentary: No slowdown in sight for high-grade primary; Bristol-Myers notes flat; ABN slightly wider
|
10/24/2013 | IG | Market Commentary: Bristol-Myers, Bank of Nova Scotia, Prologis price as strong tone continues; ABN Amro firms
|
10/24/2013 | CVIG | Moody's gives Bristol-Myers notes A2
|
10/24/2013 | CVIG | S&P: Bristol-Myers notes A+
|
10/24/2013 | IG | Bristol-Myers eyeing three-part offering due in 2019, 2023 and 2044
|
10/24/2013 | IG | New Issue: Bristol-Myers sells $1.5 billion senior notes due in 2019, 2023, 2044
|
9/23/2013 | CVIG | Moody's: Bristol-Myers view negative
|
8/30/2013 | SP | New Issue: JPMorgan prices $3.21 million autocallable contingent interest notes linked to three stocks
|
7/31/2013 | SP | New Issue: Barclays prices $2.19 million trigger phoenix autocallables linked to Bristol-Myers Squibb
|
7/24/2013 | SP | Barclays to price trigger phoenix autocallables on Bristol-Myers Squibb
|
7/1/2013 | CVIG | Fitch cuts Bristol-Myers to A-
|
5/16/2013 | CV | Bristol-Myers Squibb announces intention to delist its preferred stock
|
4/26/2013 | SP | New Issue: HSBC prices $211,000 income plus notes on five stocks with 0.5% minimum coupon
|
4/12/2013 | SP | New Issue: HSBC prices $1 million income plus notes on five stocks with 0.5% minimum coupon
|
4/2/2013 | SP | HSBC plans income plus notes on stock basket with 0.5% minimum coupon
|
4/2/2013 | SP | HSBC plans income notes due 2019 on stocks with 0.5% minimum coupon
|
3/7/2013 | SP | HSBC plans income plus notes on stock basket with 0.5% minimum coupon
|
1/4/2013 | SP | HSBC plans income plus notes on stock basket with 1% minimum coupon
|
1/4/2013 | SP | HSBC plans income plus notes on stock basket with 0.5% minimum coupon
|
1/3/2013 | SP | New Issue: HSBC prices $23,000 income plus notes tied to five stocks with 0.5% coupon floor
|
12/17/2012 | SP | HSBC plans income plus CDs on five stocks with 0.25% minimum coupon
|
12/17/2012 | SP | HSBC plans income plus CDs on five stocks with 0.5% minimum coupon
|
12/17/2012 | SP | HSBC plans income plus CDs on five stocks with 0.75% minimum coupon
|
12/4/2012 | SP | HSBC plans income plus notes on stocks with 1% minimum coupon
|
12/4/2012 | SP | HSBC plans income plus notes on stocks with 0.5% minimum coupon
|
11/29/2012 | SP | New Issue: HSBC prices $1.25 million income plus notes on five stocks with 0.5% coupon floor
|
11/1/2012 | SP | HSBC plans income plus notes on five stocks with 0.5% minimum coupon
|
11/1/2012 | SP | HSBC plans income plus notes on five stocks with 1% minimum coupon
|
8/13/2012 | CVLM | Amylin announces change-of-control put option for 3% convertibles
|
7/26/2012 | CVIGPF | S&P: Bristol-Myers Squibb notes A+, preferreds A-
|
7/26/2012 | IG | New Issue: Bristol-Myers sells $2 billion of five-, 10-, 30-year bonds
|
7/26/2012 | BK | Bristol-Myers Squibb plans $1.5 billion revolver for Amylin purchase
|
7/26/2012 | IG | Market Commentary: Bristol-Myers brings deal for M&A; Australian financials price; bank paper spreads tighten
|
7/26/2012 | CVIG | Moody's rates Bristol-Myers Squibb notes A2
|
7/26/2012 | CVIGPF | Bristol-Myers Squibb files automatic shelf for stock, preferreds, debt
|
7/3/2012 | BKCVIG | Fitch cuts Bristol Myers Squibb
|
7/2/2012 | CVIG | Moody's affirms Bristol-Myers
|
5/31/2012 | BKCVIG | S&P lifts health companies
|
1/11/2012 | CVIG | Fitch: Bristol-Myers unchanged
|
1/9/2012 | CVIG | Moody's: Bristol-Myers unaffected by acquisition
|
1/9/2012 | CVIG | S&P: Bristol-Myers unaffected
|
11/22/2011 | CVIG | Moody's: Bristol-Myers loan A2
|
10/5/2011 | BK | Bristol-Myers closes $1.5 billion five-year revolving credit facility
|
7/25/2011 | CVIG | Fitch affirms Bristol-Myers
|
12/3/2010 | IGLM | Bristol-Myers records $1.09 billion tenders in oversubscribed offer
|
11/18/2010 | IGLM | Bristol-Myers Squibb sets tender offer prices for 6.125%, 5.875% notes
|
11/17/2010 | IGLM | Bristol-Myers Squibb gets tenders for $1.09 billion of notes so far
|
11/3/2010 | IGLM | Bristol-Myers Squibb tenders for $750 million of four note series
|
9/15/2010 | SP | Credit Suisse names underwriter for $31.57 million 8% equity-linked notes on Bristol-Myers
|
9/14/2010 | SP | New Issue: Credit Suisse prices $31.57 million 8% equity-linked notes linked to Bristol-Myers Squibb
|
8/27/2010 | CVIG | Fitch: Bristol-Myers Squibb outlook negative
|
12/18/2009 | SS | Bristol-Myers Squibb's exchange offer for Mead Johnson oversubscribed
|
12/16/2009 | SS | Bristol-Myers Squibb sets exchange ratio in Mead Johnson splitoff
|
12/15/2009 | SS | Bristol-Myers Squibb sells shares of Celldex, drops stake to 5.99%
|
12/9/2009 | SS | Bristol-Myers Squibb sells shares of Celldex, drops stake to 7.83%
|
12/4/2009 | SS | Bristol-Myers Squibb extends exchange offer for Mead Johnson shares
|
11/25/2009 | SS | Bristol-Myers Squibb sells 71,625 shares of Celldex for 9.14% stake
|
11/16/2009 | CVIG | Fitch: Bristol-Myers unchanged
|
11/16/2009 | SS | Bristol-Myers Squibb to split off Mead Johnson via exchange offer
|
11/16/2009 | SS | Market Commentary: Quick close for Mead Johnson split; China key in 3Com deal; more buys predicted for Goldcorp
|
11/16/2009 | CVIG | Moody's: Bristol-Myers unchanged
|
10/26/2009 | CV | Medarex tender offer for 2.25% convertibles expires; no notes tendered
|
9/24/2009 | CV | Medarex holders may put 2.25% convertibles following change of control
|
9/1/2009 | SS | Bristol-Myers Squibb completes $16-per-share purchase of Medarex
|
8/27/2009 | SP | Credit Suisse reveals underwriter for $27.51 million 10% equity-linked notes tied to Bristol-Myers Squibb
|
8/27/2009 | SS | Bristol-Myers Squibb begins offer for remaining Medarex shares
|
8/27/2009 | IG | Fitch affirms Bristol-Myers
|
8/26/2009 | SP | Credit Suisse amends maturity date of $27.51 million 10% equity-linked notes tied to Bristol-Myers Squibb
|
8/25/2009 | SP | New Issue: Credit Suisse prices $27.51 million 10% equity-linked notes tied to Bristol-Myers Squibb
|
8/20/2009 | SS | Bristol-Myers Squibb extends tender offer for Medarex by two days
|
8/19/2009 | SS | Medarex investor Gamco buys shares ahead of Bristol-Myers merger
|
8/3/2009 | IG | Moody's lifts Bristol-Myers outlook to stable
|
7/28/2009 | SS | Bristol-Myers Squibb's tender offer for Medarex shares ends Aug. 24
|
7/24/2009 | SS | Market Commentary: Bristol-Meyers predicted to continue deal pace; proxy firm sides with Foundation Coal buyout
|
7/23/2009 | SS | Bristol-Myers Squibb, Medarex to combine in deal worth $2.4 billion
|
7/23/2009 | SS | Market Commentary: Bristol-Myers' buy narrows drug field; Noven tender opens; TransAlta offer considered risky
|
4/23/2009 | SS | Market Commentary: Centennial buyout could let AT&T walk; Emulex auction expected; major pharma mergers predicted
|
2/11/2009 | SP | ABN Amro to price 10% reverse exchangeables linked to Bristol-Myers Squibb
|
2/2/2009 | SS | Market Commentary: Second Amylin shareholder wants changes; analysts predict higher bid for CV Therapeutics
|
12/31/2008 | SP | New Issue: Barclays prices $2.5 million 9.75% reverse convertibles linked to Bristol-Myers
|
10/14/2008 | SP | RBC plans 11% reverse convertibles linked to Bristol-Myers
|
10/14/2008 | SS | Eli Lilly begins tender offer for ImClone
|
10/13/2008 | SS | Market Commentary: Morgan Stanley, Wachovia jump as deals okayed; Vishay, Waste Management, United Tech drop bids
|
10/6/2008 | SS | Eli Lilly to buy ImClone for $6.5 billion; Bristol-Myers Squibb to benefit
|
10/6/2008 | SS | Market Commentary: Wachovia war hits the courts but short truce declared; International Rectifier rebuffs Vishay
|
10/1/2008 | SS | Market Commentary: Financials up ahead of vote; NatCity leads regionals; Eli Lilly revealed as ImClone's secret bidder
|
9/30/2008 | SS | Market Commentary: Huntsman hangs on to Hexion deal; Wachovia still selling; ImClone's secret admirer stays secret
|
9/29/2008 | SP | New Issue: Barclays prices $4 million 9.5% reverse convertibles linked to Bristol-Myers
|
9/29/2008 | SS | ImClone: Unnamed company to move forward or drop offer by Oct. 1
|
9/23/2008 | SS | Icahn reacts to Bristol-Myers' 'hostile' tender offer for ImClone
|
9/23/2008 | SS | Market Commentary: Investors watch WaMu; Icahn fights for ImClone; Longs Drug Stores readies for Walgreen hostile bid
|
9/22/2008 | SS | Bristol-Myers ups offer for ImClone to $62 per share, readies for tender offer
|
9/16/2008 | SS | Bristol-Myers Squibb CFO says company would drop pursuit of ImClone under certain circumstances
|
9/12/2008 | CVIG | Fitch affirms Bristol-Myers Squibb
|
9/11/2008 | SP | Barclays to price 9.5% reverse convertibles linked to Bristol-Myers
|
9/11/2008 | SS | Bristol-Myers Squibb reacts to ImClone's rejection of its $60-per-share offer
|
9/10/2008 | SS | ImClone rejects Bristol-Myers' offer, reports new offer on the table
|
9/10/2008 | SS | Market Commentary: Bristol-Myers capable of topping $70 per share mystery bid for ImClone, says ICAP's Sachin Shah
|
8/28/2008 | SP | New Issue: Barclays prices $3.5 million 9.75% reverse convertibles linked to Bristol-Myers
|
8/27/2008 | CV | Market Commentary: Amylin, Cell Genesys fall on product bombshells; Bristol-Myers stands pat; Fannie Mae extends gains
|
8/13/2008 | SP | Barclays to price 9.75% reverse convertibles linked to Bristol-Myers
|
8/11/2008 | SS | Market Commentary: Waste Management dumps on a few dollars more; ImClone, Bristol-Myers squabble; JDS to join i2
|
8/4/2008 | SS | ImClone committee to review offer from Bristol-Myers Squibb
|
8/4/2008 | SS | Market Commentary: ImClone rejects $60 per share offer; Blackstone shops for theme parks; PeopleSupport jumps on Aegis buy
|
7/31/2008 | SS | Market Commentary: Bristol-Myers bids for ImClone; Marathon to split; Yahoo! shareholders to meet
|
7/31/2008 | CVIG | Moody's: Bristol-Myers view negative
|
7/31/2008 | SS | Bristol-Myers Squibb makes $4.5 billion offer for ImClone
|
7/30/2008 | SP | New Issue: Barclays prices $4 million 9.25% reverse convertibles linked to Bristol-Myers
|
7/11/2008 | SP | Barclays to price 9.25% reverse convertibles linked to Bristol-Myers
|
7/7/2008 | SP | New Issue: Barclays prices $5 million 9.5% reverse convertibles linked to Bristol-Myers
|
6/27/2008 | SP | New Issue: Barclays prices $6 million 9.6% reverse convertibles linked to Bristol-Myers
|
6/26/2008 | SP | Barclays to price 9.5% reverse convertibles linked to Bristol-Myers
|
6/26/2008 | SS | Bristol-Myers Squibb accepts 97.1% of Kosan Biosciences' shares to complete acquisition
|
6/18/2008 | SS | Bristol-Myers Squibb, Kosan merger clears HSR waiting period; tender offer set to end June 25
|
6/10/2008 | SP | Barclays to price 9.6% reverse convertibles linked to Bristol-Myers
|
6/6/2008 | SP | ABN Amro plans 11% knock-in notes linked to Bristol-Myers
|
5/30/2008 | SP | New Issue: ABN Amro prices $0.25 million 10.8% reverse convertibles linked to Bristol-Myers
|
5/29/2008 | SP | New Issue: Barclays prices $5 million 9.25% reverse convertibles linked to Bristol-Myers
|
5/29/2008 | SS | Bristol-Myers Squibb, Kosan Biosciences to combine in $190 million deal
|
5/29/2008 | SS | Market Commentary: Kosan Biosciences shares soar 230% as Bristol-Myers Squibb tenders at $5.50 per share
|
5/15/2008 | IG | Market Commentary: Eaton, NiSource, Deutsche Bank, Harley Davidson, HBOS price; new issue premiums continue decrease
|
5/9/2008 | SP | Barclays to price 9.25% reverse convertibles linked to Bristol-Myers Squibb
|
5/7/2008 | SP | ABN Amro plans 10.8% knock-in notes linked to Bristol-Myers Squibb
|
5/7/2008 | SP | New Issue: Barclays prices $3.5 million 10% reverse convertibles linked to Bristol-Myers
|
4/29/2008 | IG | Market Commentary: Bank of America, Fifth Third, Pearson, KLA-Tencor price ahead of Fed; flat tone seen as positive
|
4/29/2008 | SP | New Issue: Barclays prices $3.5 million 10% reverse convertibles linked to Bristol-Myers
|
4/28/2008 | CVIG | Moody's gives Bristol-Myers notes A2
|
4/28/2008 | CVIG | Fitch rates Bristol-Myers notes A+
|
4/28/2008 | CVIG | Bristol-Myers Squibb files automatic shelf registration
|
4/28/2008 | IG | New Issue: Bristol-Myers Squibb prices $1.6 billion in 10-, 30-year notes
|
4/28/2008 | IG | Market Commentary: Bristol-Myers Squibb, AMB Property price; Fifth Third, KLA-Tencor announce upcoming issues
|
4/28/2008 | CVIG | S&P assigns Bristol-Myers notes A+
|
4/8/2008 | SP | Barclays to price 10% reverse convertibles linked to Bristol-Myers Squibb
|
2/28/2008 | SP | New Issue: Barclays prices $4 million 10% reverse convertibles linked to Bristol-Myers
|
2/11/2008 | SP | Barclays to price 10% reverse convertibles linked to Bristol-Myers Squibb
|
12/17/2007 | SS | Market Commentary: Ingersoll-Rand buys Trane ticket for $10 billion; National Oilwell Varco picks up Grant Prideco for over $7 billion
|
12/10/2007 | SP | Barclays to price 9.75% reverse convertibles linked to Bristol-Myers Squibb
|
10/30/2007 | SP | New Issue: Barclays prices $2.5 million 10% reverse convertibles linked to Bristol-Myers
|
10/10/2007 | SP | Barclays to price 10% reverse convertibles linked to Bristol-Myers Squibb
|
9/27/2007 | SP | New Issue: ABN Amro prices $2.5 million 17.1% reverse convertibles linked to Bristol-Myers
|
9/26/2007 | SP | New Issue: UBS prices $4.59 million 8.3% yield optimization notes linked to Bristol-Myers Squibb
|
9/5/2007 | SP | ABN Amro to price 17.1% knock-in notes linked to Bristol-Myers Squibb
|
8/31/2007 | SP | UBS to price yield optimization notes linked to Bristol-Myers Squibb
|
8/3/2007 | CV | Fitch affirms Bristol-Myers
|
7/30/2007 | SP | New Issue: ABN Amro prices $4.3 million 13.1% reverse convertibles linked to Bristol-Myers
|
7/12/2007 | SS | Market Commentary: Alcan shines; Alcoa on the run; Huntsman slides; Lyondell up; Abbott off; ImClone declines
|
7/6/2007 | SP | ABN Amro plans 13.1% reverse exchangeable securities linked to Bristol-Myers Squibb
|
6/29/2007 | SP | New Issue: ABN Amro prices $5.3 million 13.75% knock-in notes linked to Bristol-Myers Squibb
|
6/22/2007 | CV | S&P ups Bristol-Myers outlook to stable
|
6/19/2007 | CV | Market Commentary: VeriFone improves on debut; Companhia Vale do Rio Doce gains in gray; Bristol-Myers rises on legal win
|
6/5/2007 | SP | ABN Amro plans 13.75% Knock-in Reverse Exchangeables linked to Bristol-Myers Squibb
|
5/29/2007 | SP | New Issue: Barclays prices $2.5 million 10.5% reverse convertibles linked to Bristol-Myers
|
5/9/2007 | SP | Barclays to price 10.5% reverse convertibles linked to Bristol-Myers Squibb
|
4/26/2007 | SS | Market Commentary: Nacco oscillates; Wendy's gains; Applebee's rises; Biosite bows; Harman up; new Delta slow, low
|
3/30/2007 | SP | New Issue: ABN Amro prices $1.6 million 10% three-month notes linked to Bristol-Meyers Squibb
|
3/2/2007 | SP | ABN Amro to price 2.5% three-month knock-in notes linked to Bristol-Myers Squibb
|
2/12/2007 | CV | Market Commentary: Bristol-Myers slips on dashed merger hopes; Anixter prices at rich end; Illumina seen as fair; Essex in play
|
2/12/2007 | SS | Market Commentary: Four Seasons, Hilton, Starwood slide; Southwest soars; Eddie Bauer off; WCI up; Onyx rockets
|
1/31/2007 | SS | Market Commentary: Altria, Kraft players cheer, exit; Bristol-Myers speculation widens; Google gyrates; Delta Air dives
|
1/30/2007 | CV | Market Commentary: Bristol-Myers gains further on takeover rumors; Sunpower quiet amid borrow concerns; Kyphon plans deal
|
1/30/2007 | SP | New Issue: ABN Amro prices $1.93 million 10.5% notes linked to Bristol-Myers Squibb via LaSalle
|
1/29/2007 | SS | Market Commentary: Bristol-Myers up; Harrah's slips; First Bancorp, Doral, W Holding up; Sea Containers slides; Delta better
|
1/29/2007 | CV | Market Commentary: Bristol-Myers gains amid takeover talk; Sunpower distribution could be tight; Amgen continues decline
|
1/4/2007 | SP | ABN Amro plans 10.5% knock-in notes linked to Bristol-Myers Squibb
|
11/17/2006 | CV | Moody's rates Bristol-Myers Squibb notes A2
|
11/17/2006 | CV | Fitch rates Bristol-Myers Squibb notes A+
|
11/16/2006 | BTCVHY | S&P assigns Bristol-Myers notes A+
|
10/26/2006 | BT | Bristol-Myers Squibb negatively impacted by generic Plavix
|
10/25/2006 | BT | Market Commentary: Cadence rises after pricing below range; ImClone dips, ends up 5%; PDI off by 4%; Arena rebounds 7%
|
9/21/2006 | BT | Court upholds injunction against Apotex's generic Plavix
|
9/13/2006 | BT | Bristol-Myers Squibb, Medivir to collaborate on HIV drug MIV-170
|
9/12/2006 | BTCV | Moody's cuts Bristol-Myers Squibb
|
9/12/2006 | BT | Bristol-Myers CEO, senior vice president depart posts amid Plavix case
|
9/7/2006 | BT | Sanofi-Aventis, Bristol-Myers get expanded European Plavix indication, withdraw dronedarone
|
9/6/2006 | BTCV | S&P affirms Bristol-Myers Squibb
|
9/1/2006 | BT | Injunction halts Apotex sales of generic Plavix in Sanofi-Aventis, Bristol-Myers Squibb patent case
|
8/17/2006 | BT | Sanofi-Aventis, Bristol-Myers' Plavix gets FDA approval for new indication
|
8/14/2006 | BT | Bristol-Myers Squibb study shows benefits of integrated medical care in HIV cases
|
8/14/2006 | BT | Sanofi-Aventis, Bristol Myers Squibb file motion to stop sales of Apotex' generic Plavix
|
8/14/2006 | BT | ZymoGenetics sues Bristol-Myers for infringement of fusion protein patents
|
8/10/2006 | CV | New Issue: Lehman prices $10 million 9.55% Yeelds linked to Bristol-Myers Squibb
|
8/9/2006 | BTCV | Moody's may downgrade Bristol-Myers Squibb
|
8/9/2006 | CV | Lehman plans issue of 9.55% Yeelds linked to Bristol-Myers Squibb
|
8/8/2006 | BT | Apotex launches generic Plavix; Bristol-Myers Squibb, sanofi-aventis mull legal options
|
8/8/2006 | BT | Market Commentary: Barrier loses 13%; Teva up more than 5%; Antigenics comes off highs; Amylin falls 7%
|
8/8/2006 | BTCV | S&P: Bristol-Myers Squibb on watch
|
8/8/2006 | BTCV | Fitch puts Bristol-Myers Squibb on negative watch
|
7/28/2006 | BT | Bristol-Myers, sanofi fail to receive anti-trust clearance for Plavix settlement
|
7/27/2006 | BT | Bristol-Myers Squibb posts net sales of $4.9 billion for second quarter 2006
|
7/27/2006 | BT | Bristol-Myers, sanofi say Apotex litigation settlement is under criminal investigation
|
7/17/2006 | CV | New Issue: ABN Amro prices $1.45 million 8.75% exchangeables linked to Bristol-Myers Squibb
|
7/12/2006 | BT | Bristol-Myers, Gilead get FDA approval for once-daily HIV tablet
|
7/12/2006 | CV | ABN Amro plans issue of 8.75% Knock-in Reverse Exchangeables linked to Bristol-Myers Squibb
|
6/29/2006 | BT | Aurobindo gets FDA approval for Stavudine capsules
|
6/28/2006 | BT | Bristol-Myers Squibb's Sprycel approved by FDA for treatment of adult leukemia
|
6/5/2006 | BT | Bristol-Myers releases interim data from phase 2 study in chronic myelogenous leukemia
|
6/2/2006 | BT | Bristol-Myers: FDA advisory committee votes in favor of dasatinib
|
6/1/2006 | BT | Bristol-Myers Squibb adds biologics facility in Massachusetts
|
5/31/2006 | BT | Bristol-Myers Squibb extends neuroscience alliance with Lexicon Genetics
|
5/25/2006 | BT | Bristol-Myers, Otsuka schizophrenia study shows positive results
|
5/23/2006 | BT | Bristol-Myers says Baraclude suppresses viral load in 94% of hepatitis B patients
|
5/18/2006 | BT | Bristol-Myers Squibb discontinues development of muraglitazar for type 2 diabetes
|
5/5/2006 | BT | Bristol-Myers gets third-party manufacturing approval to produce Orencia
|
4/27/2006 | BT | Bristol-Myers Squibb first-quarter net sales up 3%; earnings rise
|
4/27/2006 | BT | Bristol-Myers Squibb, Gilead submit NDA for once-daily single tablet regimen for HIV
|
3/30/2006 | BT | Cadence completes acquisition of IV acetaminophen from Bristol-Myers
|
3/22/2006 | BT | Credit Suisse rates Bristol-Myers at neutral
|
3/22/2006 | BT | Market Commentary: Cephalon seesaws; Nabi zooms; Endo drops; Insmed off; Elan, Biogen drop; King launches deal
|
3/21/2006 | BT | Sanofi-Aventis, Bristol-Myers settle Plavix litigation with Apotex
|
3/13/2006 | BT | Study shows no benefit of adding Plavix, Iscover to aspirin therapy to reduce risk of heart attack
|
3/8/2006 | BT | Bristol-Myers' Baraclude better than lamivudine for hepatitis B, studies find
|
3/8/2006 | BT | Bristol-Myers Squibb plans to build biologics facility in United States
|
3/1/2006 | BT | ImClone, Bristol-Myers get FDA approval of Erbitux for head and neck cancer
|
2/28/2006 | BT | Bristol-Myers, Somerset get FDA OK for Emsam skin patch for depression
|
2/15/2006 | BTCV | Moody's affirms Bristol-Myers Squibb
|
2/9/2006 | BT | Bristol-Myers Squibb announces preliminary settlement in shareholder litigation
|
1/23/2006 | BT | Bristol-Myers Squibb announces $185 million litigation settlement
|
1/18/2006 | BT | Sanofi, Bristol-Myers seek FDA approval of new indication for Plavix
|
1/17/2006 | BTCV | New Issue: Barclays sells $2.5 million 8% exchangeables linked to Bristol-Myers Squibb
|
1/17/2006 | BT | Pharmacopeia, Bristol-Myers advance rheumatoid arthritis candidate phase 1 trial
|
1/10/2006 | CV | Barclays plans issue of 8% exchangeables linked to Bristol-Myers Squibb
|
1/9/2006 | BT | Bristol-Myers Squibb, Gilead collaborate on fixed-dose HIV treatment
|
1/6/2006 | BT | Bristol-Myers Squibb, Athersys extend partnership to develop drug targets
|
1/6/2006 | BT | Repligen files patent infringement suit against Bristol-Myers Squibb for Orencia
|
1/5/2006 | BT | Bristol-Myers Squibb to develop targeted anti-cancer agents using Endocyte technology
|
1/3/2006 | BT | Bristol-Myers Squibb to up Orencia production, asks FDA for OK
|
12/30/2005 | BT | Bristol-Myers Squibb completes New Drug Application for dasatinib
|
12/23/2005 | BT | Bristol-Myers Squibb receives FDA approval for Orencia rheumatoid arthritis drug
|
12/22/2005 | BT | Bristol-Myers, Merck end collaboration on diabetes drug muraglitazar
|
12/19/2005 | BTPP | Bristol-Myers to pay $4.2 million to settle suit with Xechem that alleged antitrust violations for paclitaxel
|
12/13/2005 | BT | Bristol-Myers, sanofi's Plavix recommended for peripheral arterial disease
|
12/6/2005 | BT | Exelixis, Bristol-Myers to collaborate on development of drugs for cardiovascular, metabolic disorders
|
11/22/2005 | BT | Moody's assigns negative outlook to pharmaceutical industry
|
11/18/2005 | BT | Bristol-Myers Squibb's Reyataz creates less viral rebound than current protease inhibitors, study says
|
11/15/2005 | BT | Medarex to receive milestone payment from Bristol-Myers Squibb for anti-cancer antibody
|
11/1/2005 | BT | Moody's: Bristol-Myers on negative review
|
10/31/2005 | BT | Merck, Bristol-Myers license anti-HIV compounds to non-profit for use in poor countries
|
9/16/2005 | CV | Fitch affirms Bristol-Myers Squibb
|
8/11/2005 | BT | Bristol-Myers subsidiary gets $2.5 billion credit facility
|
8/11/2005 | BT | Market Commentary: Coley, China Medical ease back; Mpex announces venture capital; Kosan slips; Elan issues retreat
|
7/14/2005 | CV | Market Commentary: GM, Ford convertibles move up in active trade; AMD, Genzyme, airlines also gain, other sectors quiet
|
1/14/2005 | CV | Market Commentary: CNet gains 4 points; Collegiate Pacific higher; UnumProvident up; Wyeth rises, Schering drops
|
1/12/2005 | CV | S&P: Bristol-Myers Squibb unaffected
|
1/5/2005 | CV | Market Commentary: Celanese, AtheroGenics talk emerges; Delta cuts fares but convertibles quiet; OMI firmer
|
12/15/2004 | CV | New Issue: ABN Amro sells $12.5 million 11.75% reverse exchangeables linked to Bristol-Myers Squibb
|
11/2/2004 | CV | New Issue: Lehman prices $7 million 1.6% up 13.75% notes linked to Bristol-Myers
|
9/29/2004 | CV | Fitch rates Bristol-Myers Squibb A+
|
9/24/2004 | CV | Market Commentary: Calpine new issue trade seen awkward; Dobson off on buy; PMA Capital exchange seen
|
9/14/2004 | CV | Market Commentary: Allied Waste issues dumped; Interpublic mandatory eyed; Mercury rises ahead of Oracle
|
8/26/2004 | CV | New Issue: ABN Amro sells $2.6 million 9% reverse exchangeables linked to Bristol-Myers
|
8/16/2004 | CV | S&P cuts Bristol-Myers
|
5/20/2004 | CV | Market Commentary: Airline paper cheapens further, despite rise in stocks; Guilford shelf uplifts holders of rich bonds
|
3/10/2004 | CV | Market Commentary: Level 3 falls on Global Crossing meltdown; Marriott offered at par in gray market; biotechs plummet
|
2/13/2004 | CV | S&P: Bristol-Myers unaffected
|
2/12/2004 | CV | Market Commentary: Buyers propel new AMR convert; Bristol-Myers up on Erbitux news; Incyte trades at par in gray market
|
2/3/2004 | CV | Market Commentary: First Data's call catches some off guard, Delta reoffered at 97, descends to 95.75 bid; Tyco up
|
11/24/2003 | CV | Market Commentary: Market hunts for Thanksgiving deal, Ciber answers the call with small issue; trading flow low
|
10/8/2003 | CV | Market Commentary: Kodak, Placer Dome track gray market levels out of the gate; Simon positions seen lightening
|
10/7/2003 | CV | Market Commentary: Kodak bid up 2.25 points, Placer Dome up 2.5 in gray market action; Finisar, iDine emerge after close
|
10/6/2003 | CV | New Issue: Lehman prices $23.6 million 1.6% notes linked to Bristol-Myers
|
9/30/2003 | CV | Market Commentary: Williams bonds gain 2.25 points, mandatory up slightly but more sellers seen; LSI loses 4-5 points
|
9/26/2003 | CV | New Issue: Bristol-Myers prices $1 billion floater at Libor minus 50 bps, up 60%
|
9/26/2003 | CV | Market Commentary: Market not ready to swallow Bristol-Myers Squibb; Cracker Barrel drops 1.5 on dividend
|
9/25/2003 | CV | S&P rates Bristol-Myers convertible AA-
|
9/25/2003 | CV | Market Commentary: Pharma Resources gains to 104 despite complaint; Bristol-Myers jumbo seen offered at par in gray
|
9/24/2003 | CV | Bristol-Myers $1 billion floater to yield Libor minus 50 to 75 bps, up 60-65%
|
9/24/2003 | CV | Market Commentary: CKE bids beefed up to 107; Flextronics expected to lose "big points" on jury award
|
6/23/2003 | CV | New Issue: ABN Amro sells $11.5 million 10% reverse exchangeables linked to Briston-Myers
|
6/3/2002 | CV | New Issue: ABN Amro prices $16 million 11% reverse exchangeables linked to Bristol-Myers
|